<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://archsurg.ama-assn.org">
<title>Archives of Surgery recent issues</title>
<link>http://archsurg.ama-assn.org</link>
<description>Archives of Surgery is an influential peer-reviewed monthly general surgery journal able to represent a full range of regional and specialty interests as the official publication of the New England Surgical Society, the Pacific Coast Surgical Association, the Surgical Infection Society, and the Western Surgical Association.</description>
<prism:publicationName>Archives of Surgery</prism:publicationName>
<prism:issn>0004-0010</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/888?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/892?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/893?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/894?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/899?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/900?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/903?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/906?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/913?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/914?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/920?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/921?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/927?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/928?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/932?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/933?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/938?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/946?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/950?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/957?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/961?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/970?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/973?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/974?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/975?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/976?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/977?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/977-a?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/978?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/978-a?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/978-b?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/979?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/979-a?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/979-b?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/10/980?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/796?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/800?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/806?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/811?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/817?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/823?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/829?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/835?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/841?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/848?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/853?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/859?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/865?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/872?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/877?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/9/878?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/704?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/706?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/713?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/721?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/722?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/727?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/728?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/733?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/734?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/738?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/740?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/745?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/746?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/752?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/753?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/759?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/764?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/766?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/769?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/770?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/778?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/779?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/780?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/783?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/784?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/785?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/786?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/787?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/8/787-a?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/605?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/607?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/612?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/617?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/618?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/625?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/634?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/635?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/643?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/649?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/656?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/663?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/670?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/679?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/684?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/685?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/691?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/692?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/693?rss=1" />
  <rdf:li rdf:resource="http://archsurg.ama-assn.org/cgi/content/short/144/7/694?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://archsurg.ama-assn.org/icons/misc/titlereprint.gif" />
</channel>

<image rdf:about="http://archsurg.ama-assn.org/icons/misc/titlereprint.gif">
<title>Archives of Surgery</title>
<url>http://archsurg.ama-assn.org/icons/misc/titlereprint.gif</url>
<link>http://archsurg.ama-assn.org</link>
</image>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/888?rss=1">
<title><![CDATA[About This Journal [About This Journal]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/888?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:title><![CDATA[About This Journal [About This Journal]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>888</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>888</prism:startingPage>
<prism:section>About This Journal</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/892?rss=1">
<title><![CDATA[Use of a Saline Bag as a Shoulder Roll During Surgery Not Recommended [Commentary]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/892?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Pearlman, R. C.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Patient Safety/ Medical Error, Surgery, Surgical Interventions, Burns]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.164</dc:identifier>
<dc:title><![CDATA[Use of a Saline Bag as a Shoulder Roll During Surgery Not Recommended [Commentary]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>892</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>892</prism:startingPage>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/893?rss=1">
<title><![CDATA[Quantifying Access to Surgical Care [From JAMA]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/893?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Segev, D.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Medical Practice, Medical Practice, Other, Renal Diseases, Renal Diseases, Other, Surgery, Surgery, Other, Transplantation, Kidney Transplantation]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.173</dc:identifier>
<dc:title><![CDATA[Quantifying Access to Surgical Care [From JAMA]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>893</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>893</prism:startingPage>
<prism:section>From JAMA</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/894?rss=1">
<title><![CDATA[Use of Seamguard to Prevent Pancreatic Leak Following Distal Pancreatectomy [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/894?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To investigate the use of Seamguard, a bioabsorbable staple line&ndash;reinforcement product, to prevent pancreatic leak after distal pancreatectomy.</p>
<p><b>Design, Setting, and Participants&nbsp;</b> A retrospective study examined 85 consecutive patients undergoing distal pancreatectomy at an academic institution from September 5, 1997, to September 30, 2007.</p>
<p><b>Main Outcome Measures&nbsp;</b> Pancreatic fistula and overall mortality and morbidity.</p>
<p><b>Results&nbsp;</b> In February 2004, the use of Seamguard in distal pancreas resections was introduced at our institution. Indications for resection included trauma (11 patients), neoplasms (62 patients), and chronic pancreatitis (12 patients). Pancreatic leak was defined as drain output of 25 mL/d or more 7 days postoperatively with a drain amylase level of 1000 U/L or more. Pancreatic leak occurred in 10 of 38 patients (26%) undergoing conventional resection with suture ligation of the pancreatic duct or nonreinforced stapled resection vs 2 of 47 patients (4%) undergoing staple resection using Seamguard reinforcement. Multivariate analysis showed that use of Seamguard with the stapler independently decreased the risk for pancreatic fistula after distal pancreatectomy (odds ratio, 0.07; 95% confidence interval, 0.01-0.43; <I>P</I>&nbsp;=&nbsp;.01).</p>
<p><b>Conclusions&nbsp;</b> The use of Seamguard is quickly becoming a common adjunct in distal pancreas resections. Our study shows a lower incidence of pancreatic leak after distal pancreatectomy with the use of this staple line&ndash;reinforcing product.</p>
]]></description>
<dc:creator><![CDATA[Yamamoto, M., Hayashi, M. S., Nguyen, N. T., Nguyen, T. D., McCloud, S., Imagawa, D. K.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endocrine Surgery, Surgical Interventions, Other, Surgical Physiology, Surgical Physiology, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.39</dc:identifier>
<dc:title><![CDATA[Use of Seamguard to Prevent Pancreatic Leak Following Distal Pancreatectomy [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>899</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>894</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/899?rss=1">
<title><![CDATA[To Mesh or Not to Mesh, That Is the Question: Comment on "Use of Seamguard to Prevent Pancreatic Leak Following Distal Pancreatectomy" [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/899?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hawkins, W. G.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endocrine Surgery, Surgical Interventions, Other, Surgical Physiology, Surgical Physiology, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.34</dc:identifier>
<dc:title><![CDATA[To Mesh or Not to Mesh, That Is the Question: Comment on "Use of Seamguard to Prevent Pancreatic Leak Following Distal Pancreatectomy" [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>899</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>899</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/900?rss=1">
<title><![CDATA[Ischemic Colitis After Endovascular Aortoiliac Aneurysm Repair: A 10-Year Retrospective Study [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/900?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To examine the incidence, cause, and outcomes of ischemic colitis after endovascular stent graft repair of aortoiliac aneurysms (EVAR).</p>
<p><b>Design&nbsp;</b> Medical record review.</p>
<p><b>Setting&nbsp;</b> University teaching hospital.</p>
<p><b>Patients&nbsp;</b> Eight hundred nine patients treated during 10 years were included in the study. Preoperative data regarding the size of the aneurysm, hypogastric coil embolization, and inferior mesenteric artery patency were evaluated by means of computed tomographic scans and aortograms. Ischemic colitis was diagnosed by lower endoscopy or pathology reports.</p>
<p><b>Main Outcome Measures&nbsp;</b> Ischemic colitis after EVAR.</p>
<p><b>Results&nbsp;</b> Eleven patients (1.4%) developed ischemic colitis. Seven patients' episode occurred less than 30 days from repair (early), whereas 4 occurred 30 days or more from repair (late). Ten of 11 patients had preoperative inferior mesenteric artery occlusion. Microembolization was seen histologically in 2 patients in the early group, both of whom died. A significant increase in ischemic colitis was seen in patients undergoing preoperative unilateral hypogastric coil embolization (<I>P</I>&nbsp;=&nbsp;.02). Three of the patients with late ischemic colitis had comorbidities other than the EVAR to explain the ischemia.</p>
<p><b>Conclusions&nbsp;</b> The incidence of ischemic colitis is decreased in patients undergoing EVAR vs open repair. The cause of the ischemia is multifactorial and seems to differ between patients in the early and late groups. Microembolization tends to produce severe ischemic colitis and is usually fatal. There should be a low threshold for performing endoscopy in any patient thought to have ischemic colitis after EVAR.</p>
]]></description>
<dc:creator><![CDATA[Miller, A., Marotta, M., Scordi-Bello, I., Tammaro, Y., Marin, M., Divino, C.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Cardiovascular System, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Vascular Surgery, Cardiovascular Disease/ Myocardial Infarction, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.70</dc:identifier>
<dc:title><![CDATA[Ischemic Colitis After Endovascular Aortoiliac Aneurysm Repair: A 10-Year Retrospective Study [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>903</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>900</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/903?rss=1">
<title><![CDATA["Hardening of the Arteries" Is a Systemic Disease: Comment on "Ischemic Colitis After Endovascular Aortoiliac Aneurysm Repair" [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/903?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Bredenberg, C.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Cardiovascular System, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Vascular Surgery, Cardiovascular Disease/ Myocardial Infarction, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.35</dc:identifier>
<dc:title><![CDATA["Hardening of the Arteries" Is a Systemic Disease: Comment on "Ischemic Colitis After Endovascular Aortoiliac Aneurysm Repair" [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>903</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>903</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/906?rss=1">
<title><![CDATA[Role of Hepatitis B Virus Infection in the Prognosis After Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Western Dual-Center Experience [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/906?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> The role of hepatitis B virus (HBV) infection in determining the prognosis after hepatectomy for hepatocellular carcinoma (HCC) in patients with cirrhosis is controversial.</p>
<p><b>Design&nbsp;</b> Retrospective study based on multicenter prospectively updated databases.</p>
<p><b>Setting&nbsp;</b> Two tertiary referral centers specializing in hepatobiliary surgery.</p>
<p><b>Patients&nbsp;</b> Two hundred four consecutive patients with cirrhosis undergoing hepatectomy for single nodules of HCC of 5 cm or smaller from January 1, 1997, through September 30, 2006.</p>
<p><b>Interventions&nbsp;</b> Patients were divided into the following groups according to their preoperative viral status: HBV positive and hepatitis C virus (HCV) negative (group 1); HBV negative and HCV positive (group 2); HBV negative and HCV negative (group 3); and HBV positive and HCV positive (group 4).</p>
<p><b>Main Outcome Measures&nbsp;</b> A multivariate analysis was performed to determine factors associated with recurrence-free survival (RFS) among demographic, clinical, pathological, and surgical variables.</p>
<p><b>Results&nbsp;</b> The 2 centers had comparable RFS and early and late recurrence rates. Five-year RFS was significantly higher in groups 2 and 3 compared with group 1 (38%, 34%, and 9%, respectively; <I>P</I>&nbsp;=&nbsp;.007 and <I>P</I>&nbsp;=&nbsp;.05). Factors independently associated with RFS were HBV infection (<I>P</I>&nbsp;=&nbsp;.009; odds ratio, 1.79; 95% confidence interval, 1.15-2.78) and poor tumor differentiation (<I>P</I>&nbsp;&lt;&nbsp;.001; odds ratio, 2.01; 95% confidence interval, 1.36-2.96). The concomitance of 0, 1, or 2 risk factors led to 5-year RFS rates of 49%, 20%, and 8%, respectively (<I>P</I>&nbsp;&lt;&nbsp;.001).</p>
<p><b>Conclusions&nbsp;</b> Infection with HBV is a strong predictive factor for lower RFS after hepatectomy for a single nodule of HCC of 5 cm or smaller in patients with cirrhosis, providing a further basis for adjuvant antiviral treatment. Patients who are seropositive for HBV with poorly differentiated HCC should also be considered to be at a high risk of recurrence and possibly included in a policy of salvage liver transplantation.</p>
]]></description>
<dc:creator><![CDATA[Cescon, M., Cucchetti, A., Grazi, G. L., Ferrero, A., Vigano, L., Ercolani, G., Ravaioli, M., Zanello, M., Andreone, P., Capussotti, L., Pinna, A. D.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Oncology, Other, Surgery, Surgical Interventions, Surgical Oncology, Surgical Physiology, Surgical Infections, Prognosis/ Outcomes, Hepatobiliary Surgery, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.99</dc:identifier>
<dc:title><![CDATA[Role of Hepatitis B Virus Infection in the Prognosis After Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Western Dual-Center Experience [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>913</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>906</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/913?rss=1">
<title><![CDATA[HBV and HCC: Comment on "Role of Hepatitis B Virus Infection in the Prognosis After Hepatectomy for Hepatocellular Carcinomain Patients With Cirrhosis:A Western Dual-Center Experience" [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/913?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Levi, D., Tzakis, A.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Oncology, Other, Surgery, Surgical Interventions, Surgical Oncology, Surgical Physiology, Surgical Infections, Prognosis/ Outcomes, Hepatobiliary Surgery, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.98</dc:identifier>
<dc:title><![CDATA[HBV and HCC: Comment on "Role of Hepatitis B Virus Infection in the Prognosis After Hepatectomy for Hepatocellular Carcinomain Patients With Cirrhosis:A Western Dual-Center Experience" [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>913</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>913</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/914?rss=1">
<title><![CDATA[Predictors of Long-term Mortality After Bariatric Surgery Performed in Veterans Affairs Medical Centers [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/914?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> The purpose of this study was to examine patient factors associated with mortality among veterans who undergo bariatric surgery.</p>
<p><b>Design&nbsp;</b> Prospective study that uses data from the Veterans Affairs (VA) National Surgical Quality Improvement Program.</p>
<p><b>Setting&nbsp;</b> Group Health Center for Health Studies, the VA North Texas Health Care System, the Denver VA Medical Center, and the Durham VA Medical Center.</p>
<p><b>Patients&nbsp;</b> We identified 856 veterans who had undergone bariatric surgery in 1 of 12 VA bariatric centers from January 1, 2000, through December 31, 2006.</p>
<p><b>Main Outcome Measures&nbsp;</b> The risk of death was estimated via Cox proportional hazards.</p>
<p><b>Results&nbsp;</b> The 856 veterans had a mean body mass index (BMI) of 48.7, a mean age of 54 years, and a mean DCG score of 0.76; 73.0% were men, 83.9% were white, and 7.0% had an ASA class equal to 4. Fifty-four veterans (6.3%) had died by the end of 2006. In our Cox models, patients with a BMI greater than 50 (superobesity; hazard ratio [HR], 1.8; <I>P</I>&nbsp;=&nbsp;.04) or a DCG score greater than or equal to 2 (HR, 3.4; <I>P</I>&nbsp;&lt;&nbsp;.001) had an increased risk of death.</p>
<p><b>Conclusion&nbsp;</b> Superobese veterans and those with a greater burden of chronic disease had a greater risk of death after bariatric surgery from 2000 through 2006.</p>
]]></description>
<dc:creator><![CDATA[Arterburn, D., Livingston, E. H., Schifftner, T., Kahwati, L. C., Henderson, W. G., Maciejewski, M. L.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Public Health, Obesity, Surgery, Surgical Interventions, Bariatric Surgery, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.134</dc:identifier>
<dc:title><![CDATA[Predictors of Long-term Mortality After Bariatric Surgery Performed in Veterans Affairs Medical Centers [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>920</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>914</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/920?rss=1">
<title><![CDATA[Possible Lack of Survival Advantage for One Group: Comment on "Predictors of Long-term Mortality After Bariatric Surgery Performed in Veterans Affairs Medical Centers" [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/920?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Deveney, C. W.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Public Health, Obesity, Surgery, Surgical Interventions, Bariatric Surgery, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.135</dc:identifier>
<dc:title><![CDATA[Possible Lack of Survival Advantage for One Group: Comment on "Predictors of Long-term Mortality After Bariatric Surgery Performed in Veterans Affairs Medical Centers" [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>920</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>920</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/921?rss=1">
<title><![CDATA[Late Results of the Surgical Treatment of 125 Patients With Short-Segment Barrett Esophagus [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/921?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> The results of surgical treatment of patients with long-segment Barrett esophagus (BE) have been extensively reported. However, few publications refer to the results of surgery 5 years after the fact among patients with short-segment BE. This study aimed to determine the late results of 3 surgical procedures in patients with short-segment BE by subjective and objective measurements.</p>
<p><b>Design&nbsp;</b> Prospective, nonrandomized study starting on March 1, 1987, and ending on December 31, 2005.</p>
<p><b>Setting&nbsp;</b> A prospective, descriptive study of a group of patients.</p>
<p><b>Patients&nbsp;</b> A total of<b></b> 125 patients with short-segment BE underwent 3 operations in different periods: duodenal switch plus highly selective vagotomy and antireflux technique in 31 patients, vagotomy plus partial gastrectomy and Roux-en-Y loop with antireflux surgery in 58 patients, and laparoscopic Nissen fundoplication in 36 patients.</p>
<p><b>Main Outcome Measures&nbsp;</b> Late subjective and objective outcomes of the 3 different surgical procedures.</p>
<p><b>Results&nbsp;</b> No operative mortality and only 2 postoperative complications (1.6%) occurred. The regression from intestinal metaplasia to cardiac or oxyntocardiac mucosa occurred in 60.8% to 65.4% of the patients, at a mean time of 39 to 56 months after surgery. Visick grading showed Visick grade I or II in 86.3% to 100.0% of the patients. No progression to low- or high-grade dysplasia or adenocarcinoma occurred.</p>
<p><b>Conclusions&nbsp;</b> On the basis of these results, laparoscopic Nissen fundoplication seems to be the surgical option for patients with short-segment BE because it is less invasive, has fewer side effects, and produces good results in the long-term follow-up.</p>
]]></description>
<dc:creator><![CDATA[Csendes, A., Braghetto, I., Burdiles, P., Smok, G., Henriquez, A., Burgos, A. M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Gastrointestinal/ Upper Foregut, Prognosis/ Outcomes, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.83</dc:identifier>
<dc:title><![CDATA[Late Results of the Surgical Treatment of 125 Patients With Short-Segment Barrett Esophagus [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>927</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>921</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/927?rss=1">
<title><![CDATA[Questions Regarding Surgery to Correct Short-Segment BE: Comment on "Late Results of the Surgical Treatment of 125 Patients With Short-Segment Barrett Esophagus" [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/927?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[DeMeester, S. R.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Gastrointestinal/ Upper Foregut, Prognosis/ Outcomes, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.84</dc:identifier>
<dc:title><![CDATA[Questions Regarding Surgery to Correct Short-Segment BE: Comment on "Late Results of the Surgical Treatment of 125 Patients With Short-Segment Barrett Esophagus" [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>927</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>927</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/928?rss=1">
<title><![CDATA[Pulmonary Embolism and Deep Venous Thrombosis in Trauma: Are They Related? [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/928?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Pulmonary embolism (PE) and deep venous thrombosis (DVT) in trauma are related.</p>
<p><b>Design&nbsp;</b> Retrospective review of medical records.</p>
<p><b>Setting&nbsp;</b> Academic level I trauma center.</p>
<p><b>Patients&nbsp;</b> Trauma patients who underwent computed tomographic pulmonary angiography (CTPA) with computed tomographic venography (CTV) of the pelvic and proximal lower extremity veins over a 3-year period (January 1, 2004, to December 31, 2006) were reviewed. Data on demographics, injury type and severity, imaging findings, hospital length of stay, and mortality were collected.</p>
<p><b>Main Outcome Measures&nbsp;</b> Pulmonary embolism and DVT.</p>
<p><b>Results&nbsp;</b> Among 247 trauma patients undergoing CTPA/CTV, PE was diagnosed in 46 (19%) and DVT in 18 (7%). Eighteen PEs were central (main or lobar pulmonary arteries), and 28 PEs were peripheral (segmental or subsegmental branches). Pulmonary embolism occurred within the first week of injury in two-thirds of patients. Seven patients with PE (4 femoral, 2 popliteal, and 1 iliac) had DVT. Pulmonary embolism was central in 5 patients and peripheral in 2 patients. No significant differences were noted in any of the examined variables between patients with PE having DVT and those not having DVT.</p>
<p><b>Conclusions&nbsp;</b> Few patients with PE have DVT of the pelvic or proximal lower extremity veins. Pulmonary embolism may not originate from these veins, as commonly believed, but instead may occur de novo in the lungs. These findings have implications for thromboprophylaxis and, particularly, the value of vena cava filters.</p>
]]></description>
<dc:creator><![CDATA[Velmahos, G. C., Spaniolas, K., Tabbara, M., Abujudeh, H. H., de Moya, M., Gervasini, A., Alam, H. B.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:01 PDT</dc:date>
<dc:subject><![CDATA[Venous Thromboembolism, Otolaryngology/ Head & Neck Surgery, Radiology of Head & Neck, Cardiovascular System, Pulmonary Diseases, Pulmonary Diseases, Other, Radiologic Imaging, Surgery, Surgical Interventions, Vascular Surgery, Diagnosis, Angiology, Ultrasonography, Radiologic Imaging, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.97</dc:identifier>
<dc:title><![CDATA[Pulmonary Embolism and Deep Venous Thrombosis in Trauma: Are They Related? [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>932</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>928</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/932?rss=1">
<title><![CDATA[Searching for the Source of Venous Clots: An Unsolved Old Problem: Comment on "Pulmonary Embolism and Deep Venous Thrombosis in Trauma: Are They Related?" [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/932?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Coimbra, R.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Venous Thromboembolism, Otolaryngology/ Head & Neck Surgery, Radiology of Head & Neck, Cardiovascular System, Pulmonary Diseases, Pulmonary Diseases, Other, Radiologic Imaging, Surgery, Surgical Interventions, Vascular Surgery, Diagnosis, Angiology, Ultrasonography, Radiologic Imaging, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.144.10.932</dc:identifier>
<dc:title><![CDATA[Searching for the Source of Venous Clots: An Unsolved Old Problem: Comment on "Pulmonary Embolism and Deep Venous Thrombosis in Trauma: Are They Related?" [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>932</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>932</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/933?rss=1">
<title><![CDATA[Continuous Postoperative Blood Glucose Monitoring and Control by Artificial Pancreas in Patients Having Pancreatic Resection: A Prospective Randomized Clinical Trial [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/933?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate a closed-loop system providing continuous monitoring and strict control of perioperative blood glucose following pancreatic resection.</p>
<p><b>Design&nbsp;</b> Prospective, randomized clinical trial.</p>
<p><b>Patients&nbsp;</b> Thirty patients who had pancreatic resection for pancreatic neoplasm.</p>
<p><b>Interventions&nbsp;</b> Patients were prospectively randomized. Perioperative blood glucose levels were continuously monitored using an artificial endocrine pancreas (STG-22). Glucose levels were controlled using either the sliding scale method (sliding scale group, n&nbsp;=&nbsp;13) or the artificial pancreas (artificial pancreas group, n&nbsp;=&nbsp;17).</p>
<p><b>Main Outcome Measures&nbsp;</b> Incidence of severe hypoglycemia (&lt;40 mg/dL) during the intensive care period following pancreatic resection in patients monitored with the artificial pancreas. The secondary outcome measure was the total amount of insulin required for glycemic control in the first 18 hours after pancreatic resection in each patient group.</p>
<p><b>Results&nbsp;</b> In the sliding scale group, postoperative blood glucose levels rose initially before reaching a plateau of approximately 200 mg/dL between 4 and 6 hours after pancreatectomy. The levels remained high for 18 hours postoperatively. In the artificial pancreas group, blood glucose levels reduced steadily, reaching the target zone (80-110 mg/dL) by 6 hours after surgery. The total insulin dose administered per patient during the first postoperative 18 hours was significantly higher in the artificial pancreas group (mean [SD], 107&nbsp;[109] IU) than the sliding scale group (8&nbsp;[6] IU; <I>P</I>&nbsp;&lt;&nbsp;.01). Neither group showed hypoglycemia.</p>
<p><b>Conclusions&nbsp;</b> Perioperative use of an artificial endocrine pancreas to control pancreatogenic diabetes after pancreatic resection is an easy and effective way to maintain near-normal blood glucose levels. The artificial pancreas shows promise for use as insulin treatment for patients with pancreatogenic diabetes after pancreatic resection.</p>
]]></description>
<dc:creator><![CDATA[Okabayashi, T., Nishimori, I., Yamashita, K., Sugimoto, T., Maeda, H., Yatabe, T., Kohsaki, T., Kobayashi, M., Hanazaki, K.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Nutritional and Metabolic Disorders, Critical Care/ Intensive Care Medicine, Nutritional and Metabolic Disorders, Other, Surgery, Surgical Interventions, Endocrine Surgery, Randomized Controlled Trial, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.176</dc:identifier>
<dc:title><![CDATA[Continuous Postoperative Blood Glucose Monitoring and Control by Artificial Pancreas in Patients Having Pancreatic Resection: A Prospective Randomized Clinical Trial [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>937</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>933</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/938?rss=1">
<title><![CDATA[Statin Use and the Risk of Surgical Site Infections in Elderly Patients Undergoing Elective Surgery [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/938?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To examine whether preoperative statin use is associated with a reduced risk of surgical site infections.</p>
<p><b>Design, Setting, and Patients&nbsp;</b> Population-based retrospective cohort study of all elderly patients undergoing elective surgery in Ontario from April 1, 1992, through March 31, 2006. Preoperative statin use was identified using provincewide pharmacy records. Procedure and patient characteristics were derived from hospital and physician claims databases within Canada's single-payer universal health care system.</p>
<p><b>Main Outcome Measure&nbsp;</b> The 30-day risk of surgical site infection was derived from the initial admission, outpatient consultations, and hospital readmissions.</p>
<p><b>Results&nbsp;</b> The cohort included 469&nbsp;349 distinct elderly patients undergoing elective surgery, of whom 68&nbsp;387 (14.6%) were statin users. The primary analysis included 53&nbsp;565 statin users matched to 53&nbsp;565 statin nonusers undergoing the same procedure in the same hospital by the same surgeon. Unadjusted analysis revealed a slight increase in the risk of surgical site infection among statin users compared with nonusers (8.9% vs 8.7%; <I>P</I>&nbsp;&lt;&nbsp;.001), which disappeared after adjustment for demographics, health care utilization variables, comorbidities, and concurrent medication therapy (odds ratio, 1.00; 95% confidence interval, 0.95-1.04; <I>P</I>&nbsp;=&nbsp;.85). A similar lack of association was seen when matching was extended to include propensity scores (odds ratio, 0.99; 95% confidence interval, 0.94-1.05; <I>P</I>&nbsp;=&nbsp;.82). The lack of association persisted across pharmacologic, patient, and procedure subgroups.</p>
<p><b>Conclusions&nbsp;</b> Statin use is not associated with an altered risk of surgical site infection. Prevention efforts should be directed toward other evidence-based strategies.</p>
]]></description>
<dc:creator><![CDATA[Daneman, N., Thiruchelvam, D., Redelmeier, D. A.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Aging/ Geriatrics, Surgery, Surgical Interventions, Surgical Interventions, Other, Surgical Physiology, Surgical Infections, Drug Therapy, Drug Therapy, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.167</dc:identifier>
<dc:title><![CDATA[Statin Use and the Risk of Surgical Site Infections in Elderly Patients Undergoing Elective Surgery [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>945</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>938</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/946?rss=1">
<title><![CDATA[Management and Treatment of Iliopsoas Abscess [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/946?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Even with improved diagnostic modalities, the optimum management strategy for iliopsoas abscess (IPA) is not uniform, and a better understanding of treatment options is needed.</p>
<p><b>Design&nbsp;</b> Retrospective case series.</p>
<p><b>Setting&nbsp;</b> Academic center.</p>
<p><b>Patients&nbsp;</b> Sixty-one consecutive patients diagnosed as having IPA at the Mount Sinai Medical Center, New York, New York, from August 1, 2000, to December 30, 2007.</p>
<p><b>Main Outcome Measures&nbsp;</b> Development and cause of IPA, the need for additional interventions, morbidity, and mortality.</p>
<p><b>Results&nbsp;</b> The mean age of the patients was 53 years. Most patients were initially seen with pain (95% [58 of 61]), gastrointestinal tract complaints (43% [26 of 61]), and lower extremity pain (30% [18 of 61]). Primary and secondary abscesses occurred in 11% (7 of 61) and 89% (54 of 61), respectively. The most frequent underlying cause of secondary abscesses was inflammatory bowel disease. Broad-spectrum antibiotics were prescribed in all patients. Computed tomography was the most common diagnostic modality used. Abscesses were larger than 6 cm in 39% of patients (24 of 61), bilateral in 13% (8 of 61), and multiple in 25% (15 of 61). Nine patients were treated using antibiotics alone, with a success rate of 78% (7 of 9). Forty-eight patients initially underwent percutaneous drainage, which was successful in 40% (19 of 48). Among those with unresolved IPAs, 71% of patients ultimately required surgery, and the IPAs were typically associated with underlying gastrointestinal tract causes. Seven percent (4 of 61) of patients directly underwent exploratory surgery and drainage, and all of these interventions were successful. The overall mortality was 5% (3 of 61).</p>
<p><b>Conclusions&nbsp;</b> Iliopsoas abscess remains a therapeutic challenge. Gastrointestinal tract disease is the most common cause, with computed tomography as the diagnostic modality of choice. Percutaneous drainage remains the initial treatment modality but is rarely the sole therapy required. Patients with inflammatory bowel disease are likely to require ultimate operative management.</p>
]]></description>
<dc:creator><![CDATA[Tabrizian, P., Nguyen, S. Q., Greenstein, A., Rajhbeharrysingh, U., Divino, C. M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Surgical Interventions, Other, Surgical Physiology, Surgical Infections, Diagnosis, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.144</dc:identifier>
<dc:title><![CDATA[Management and Treatment of Iliopsoas Abscess [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>949</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>946</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/950?rss=1">
<title><![CDATA[Establishing Standards of Quality for Elderly Patients Undergoing Pancreatic Resection [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/950?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate pancreatic surgery as a model for high-acuity surgery in elderly patients for immediate and long-term outcomes, predictors of adverse outcomes, and hospital costs.</p>
<p><b>Design&nbsp;</b> Retrospective case series.</p>
<p><b>Setting&nbsp;</b> University tertiary care referral center.</p>
<p><b>Patients&nbsp;</b> Four hundred twelve consecutive patients who underwent pancreatic resection from October 1, 2001, through March 31, 2008, for benign and malignant periampullary conditions.</p>
<p><b>Main Outcome Measures&nbsp;</b> Clinical outcomes were compared for elderly (&ge;75 years) and nonelderly patient cohorts. Quality assessment analyses were performed to show the differential impact of complications and resource utilization between the groups.</p>
<p><b>Results&nbsp;</b> The elderly cohort constituted one-fifth of all patients. Benchmark standards of quality were achieved in this group, including low operative mortality (1%). Despite higher patient acuity, clinical outcomes were comparable to those of nonelderly patients at a marginal cost increase (median, $2202 per case). Cost modeling analysis showed further that minor and moderate complications were more frequent but no more debilitating for elderly patients. Major complications, however, were far more threatening to older patients. In these cases, duration of hospital stay doubled, and invasive interventions were more commonly deployed.</p>
<p><b>Conclusions&nbsp;</b> Quality standards for pancreatic resection in the elderly can&mdash;and should&mdash;mirror those for younger patients. Age-related care, including geriatric consultation, supplemental enteral nutrition, and early rehabilitation placement planning, can be designed to mitigate the impact of complications in the elderly and guarantee quality.</p>
]]></description>
<dc:creator><![CDATA[Pratt, W. B., Gangavati, A., Agarwal, K., Schreiber, R., Lipsitz, L. A., Callery, M. P., Vollmer, C. M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Aging/ Geriatrics, Surgery, Surgical Interventions, Endocrine Surgery, Surgical Oncology, Prognosis/ Outcomes, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.107</dc:identifier>
<dc:title><![CDATA[Establishing Standards of Quality for Elderly Patients Undergoing Pancreatic Resection [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>956</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>950</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/957?rss=1">
<title><![CDATA[Transumbilical Laparoscopic Cholecystectomy: A Novel Technique [Operative Technique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/957?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To describe a novel technique for performing laparoscopic cholecystectomies using no proprietary or specially designed equipment, while still minimizing the incision and leaving a nearly invisible scar.</p>
<p><b>Design&nbsp;</b> Retrospective review.</p>
<p><b>Setting&nbsp;</b> Community teaching hospital.</p>
<p><b>Patients&nbsp;</b> Twelve patients having uncomplicated laparoscopic cholecystectomy.</p>
<p><b>Main Outcome Measures&nbsp;</b> Number and appearance of postoperative scars.</p>
<p><b>Results&nbsp;</b> Twelve attempts to perform the procedure with our new technique were completed successfully. None of the patients required conversion to the standard technique, which requires additional ports. All of the patients were pleased with their results. No identifiable mark was visible in the right upper quadrant of any of the patients; at the 2-week follow-up, the umbilical incisions were nearly invisible, even to the patients.</p>
<p><b>Conclusion&nbsp;</b> This novel technique can be performed safely and effectively while minimizing the number and extent of incisions.</p>
]]></description>
<dc:creator><![CDATA[Dunning, K., Kohli, H.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Hepatobiliary Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.165</dc:identifier>
<dc:title><![CDATA[Transumbilical Laparoscopic Cholecystectomy: A Novel Technique [Operative Technique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>960</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>957</prism:startingPage>
<prism:section>Operative Technique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/961?rss=1">
<title><![CDATA[Consensus Review of Optimal Perioperative Care in Colorectal Surgery: Enhanced Recovery After Surgery (ERAS) Group Recommendations [Review Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/961?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To describe a consensus review of optimal perioperative care in colorectal surgery and to provide consensus recommendations for each item of an evidence-based protocol for optimal perioperative care.</p>
<p><b>Data Sources&nbsp;</b> For every item of the perioperative treatment pathway, available English-language literature has been examined.</p>
<p><b>Study Selection&nbsp;</b> Particular attention was paid to meta-analyses, randomized controlled trials, and systematic reviews.</p>
<p><b>Data Extraction&nbsp;</b> A consensus recommendation for each protocol item was reached after critical appraisal of the literature by the group.</p>
<p><b>Data Synthesis&nbsp;</b> For most protocol items, recommendations are based on good-quality trials or meta-analyses of such trials.</p>
<p><b>Conclusions&nbsp;</b> The Enhanced Recovery After Surgery (ERAS) Group presents a comprehensive evidence-based consensus review of perioperative care for colorectal surgery. It is based on the evidence available for each element of the multimodal perioperative care pathway.</p>
]]></description>
<dc:creator><![CDATA[Lassen, K., Soop, M., Nygren, J., Cox, P. B. W., Hendry, P. O., Spies, C., von Meyenfeldt, M. F., Fearon, K. C. H., Revhaug, A., Norderval, S., Ljungqvist, O., Lobo, D. N., Dejong, C. H. C., for the Enhanced Recovery After Surgery (ERAS) Group]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Evidence-Based Medicine, Surgery, Surgical Interventions, Colorectal Surgery, Review, Gastroenterology, Gastroenterology, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.170</dc:identifier>
<dc:title><![CDATA[Consensus Review of Optimal Perioperative Care in Colorectal Surgery: Enhanced Recovery After Surgery (ERAS) Group Recommendations [Review Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>969</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>961</prism:startingPage>
<prism:section>Review Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/970?rss=1">
<title><![CDATA[Simultaneous Bicavitary Hyperthermic Chemoperfusion in the Management of Pseudomyxoma Peritonei With Synchronous Pleural Extension [Resident's Forum]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/970?rss=1</link>
<description><![CDATA[
<p>Extra-abdominal spread of pseudomyxoma peritonei (PMP) is a rare event, but extension of the tumor beyond the abdomen into the pleural cavity has been reported. We report a case with synchronous pleural manifestation of PMP confirmed during abdominal cytoreductive surgery that was managed by simultaneous bicavitary hyperthermic chemoperfusion. To the best of our knowledge, this is the first report of bicavitary hyperthermic chemoperfusion for PMP. During the abdominal cytoreductive surgery in a patient with known history of PMP, extensive disease under the right hemidiaphragm was noted, requiring partial diaphragmatic resection. Once the pleural space was entered, separate mucinous deposits on the pleural surface of the diaphragm and lung surface were observed. The involved portion of the right hemidiaphragm and lung were resected. The diaphragmatic defect was left open during the hyperthermic chemoperfusion to treat both the pleural and peritoneal surfaces. The patient's postoperative course was uneventful. Simultaneous bicavitary hyperthermic chemoperfusion is a potential therapeutic option for patients with pleural extension identified during cytoreductive surgery.</p>
]]></description>
<dc:creator><![CDATA[Senthil, M., Harrison, L. E.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Oncology, Other, Surgery, Surgical Interventions, Surgical Oncology, Thoracic Surgery, Drug Therapy, Drug Therapy, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.166</dc:identifier>
<dc:title><![CDATA[Simultaneous Bicavitary Hyperthermic Chemoperfusion in the Management of Pseudomyxoma Peritonei With Synchronous Pleural Extension [Resident's Forum]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>972</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>970</prism:startingPage>
<prism:section>Resident's Forum</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/973?rss=1">
<title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/973?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kandil, E., King, S., Alabbas, H., Moroz, K., Wright, M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Breast Cancer, Oncology, Other, Radiologic Imaging, Surgery, Surgical Interventions, Colorectal Surgery, Surgical Oncology, Diagnosis, Computed Tomography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.172-a</dc:identifier>
<dc:title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>973</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>973</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/974?rss=1">
<title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/974?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Breast Cancer, Oncology, Other, Radiologic Imaging, Surgery, Surgical Interventions, Colorectal Surgery, Surgical Oncology, Diagnosis, Computed Tomography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.172-b</dc:identifier>
<dc:title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>974</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>974</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/975?rss=1">
<title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/975?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Khalaileh, A., Adileh, M., Schlager, A., Abu-Gazalah, S., Mintz, Y., Rivkind, A. I., Keidar, A.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Radiologic Imaging, Surgery, Surgical Interventions, Colorectal Surgery, Diagnosis, Computed Tomography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.171-a</dc:identifier>
<dc:title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>975</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>975</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/976?rss=1">
<title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/976?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Radiologic Imaging, Surgery, Surgical Interventions, Colorectal Surgery, Diagnosis, Computed Tomography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.171-b</dc:identifier>
<dc:title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>976</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>976</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/977?rss=1">
<title><![CDATA[Feasibility of Colonic and Gastric Standard Laparoscopic Procedures With a Single Skin Incision Approach [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/977?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Huscher, C. G., Mingoli, A., Sgarzini, G., Brachini, G., Binda, B.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Colorectal Surgery, Endoscopy/ Minimally Invasive Surgery, Surgical Interventions, Other, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.168</dc:identifier>
<dc:title><![CDATA[Feasibility of Colonic and Gastric Standard Laparoscopic Procedures With a Single Skin Incision Approach [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>977</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>977</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/977-a?rss=1">
<title><![CDATA[Feasibility of Colonic and Gastric Standard Laparoscopic Procedures With a Single Skin Incision Approach--Reply [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/977-a?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cahill, R. A., Leroy, J., Asakuma, M., Dallemagne, B., Marescaux, J.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Colorectal Surgery, Endoscopy/ Minimally Invasive Surgery, Surgical Interventions, Other, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.169</dc:identifier>
<dc:title><![CDATA[Feasibility of Colonic and Gastric Standard Laparoscopic Procedures With a Single Skin Incision Approach--Reply [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>978</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>977</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/978?rss=1">
<title><![CDATA[No Anastomotic Leaks After Colorectal Surgery in Rural Community Hospitals [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/978?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Schittek, A.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Quality of Care, Other, Surgery, Surgical Interventions, Colorectal Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.174</dc:identifier>
<dc:title><![CDATA[No Anastomotic Leaks After Colorectal Surgery in Rural Community Hospitals [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>978</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>978</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/978-a?rss=1">
<title><![CDATA[No Anastomotic Leaks After Colorectal Surgery in Rural Community Hospitals--Reply [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/978-a?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Damrauer, S. M., Bordeianou, L., Berger, D.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Quality of Care, Other, Surgery, Surgical Interventions, Colorectal Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.175</dc:identifier>
<dc:title><![CDATA[No Anastomotic Leaks After Colorectal Surgery in Rural Community Hospitals--Reply [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>978</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>978</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/978-b?rss=1">
<title><![CDATA[Fluorescent Indocyanine Green for Imaging of Bile Ducts During Laparoscopic Cholecystectomy [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/978-b?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Pertsemlidis, D.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Hepatobiliary Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.179</dc:identifier>
<dc:title><![CDATA[Fluorescent Indocyanine Green for Imaging of Bile Ducts During Laparoscopic Cholecystectomy [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>978</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>978</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/979?rss=1">
<title><![CDATA[Patient Safety in Laparoscopic Cholecystectomy [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/979?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Agarwal, B. B.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Patient Safety/ Medical Error, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Hepatobiliary Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.180</dc:identifier>
<dc:title><![CDATA[Patient Safety in Laparoscopic Cholecystectomy [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>979</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>979</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/979-a?rss=1">
<title><![CDATA[Patient Safety in Laparoscopic Cholecystectomy--Reply [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/979-a?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ishizawa, T., Bandai, Y., Kokudo, N.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Patient Safety/ Medical Error, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Hepatobiliary Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.181</dc:identifier>
<dc:title><![CDATA[Patient Safety in Laparoscopic Cholecystectomy--Reply [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>979</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>979</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/979-b?rss=1">
<title><![CDATA[Hospital Costs of Conventional and Stapled 1-Day Hemorrhoidectomy [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/979-b?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cariati, A.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Colorectal Surgery, Endoscopy/ Minimally Invasive Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.177</dc:identifier>
<dc:title><![CDATA[Hospital Costs of Conventional and Stapled 1-Day Hemorrhoidectomy [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>980</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>979</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/10/980?rss=1">
<title><![CDATA[Hospital Costs of Conventional and Stapled 1-Day Hemorrhoidectomy--Reply [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/10/980?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Giordano, P., Gravante, G., Ovens, L., Nastro, P.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:02 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Colorectal Surgery, Endoscopy/ Minimally Invasive Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.178</dc:identifier>
<dc:title><![CDATA[Hospital Costs of Conventional and Stapled 1-Day Hemorrhoidectomy--Reply [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>980</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>980</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/796?rss=1">
<title><![CDATA[About This Journal [About This Journal]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/796?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:title><![CDATA[About This Journal [About This Journal]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>796</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>796</prism:startingPage>
<prism:section>About This Journal</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/800?rss=1">
<title><![CDATA[Influence of Endocrine Surgery on General Surgery and Surgical Science [Presidential Address]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/800?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Clark, O. H.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endocrine Surgery, Surgery, Other, Humanities, History of Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.159</dc:identifier>
<dc:title><![CDATA[Influence of Endocrine Surgery on General Surgery and Surgical Science [Presidential Address]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>805</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>800</prism:startingPage>
<prism:section>Presidential Address</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/806?rss=1">
<title><![CDATA[Relevance of the ADAM and UK Small Aneurysm Trial Data in the Age of Endovascular Aneurysm Repair [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/806?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Neither the ADAM nor the UK Small Aneurysm trials showed an advantage for early open surgical repair of abdominal aortic aneurysms (AAAs) smaller than 5.5 cm in diameter. The rigorous exclusion criteria of these studies, however, limited surgery to low-risk patients. We tested the hypothesis that endovascular aneurysm repair (EVAR) has been successfully used for higher-risk patients, thus questioning the utility of the ADAM and UK Small Aneurysm trials exclusion criteria in EVAR patient selection.</p>
<p><b>Design&nbsp;</b> Retrospective case review.</p>
<p><b>Setting&nbsp;</b> An urban Veterans Affairs Medical Center.</p>
<p><b>Patients&nbsp;</b> Forty-four consecutive cases of patients with AAA who received EVAR.</p>
<p><b>Main Outcome Measures&nbsp;</b> Electronic medical records were accessed for 11 high-risk conditions that would have excluded patients from the open surgery trials, and 30-day interventional morbidity and mortality data were collected.</p>
<p><b>Results&nbsp;</b> The mean (SD) age of patients who underwent EVAR was 73.2 (10.3) years, with a mean (SD) AAA diameter of 5.8 (1.6) cm. Of 44 patients, 19 (43%) met at least 1 exclusion criterion that would have prevented randomization in the small AAA trials. Significant perioperative complications occurred in 14 patients (32%) and 1 death occurred at home within 30 days of the procedure.</p>
<p><b>Conclusions&nbsp;</b> Patients receiving EVAR at an urban Veterans Affairs Medical Center had a greater prevalence of high-risk conditions than patients included in the ADAM and UK Small Aneurysm trials, and overall perioperative morbidity and mortality were lower. Endovascular aneurysm repair has extended aneurysm repair to a higher-risk population with greater safety.</p>
]]></description>
<dc:creator><![CDATA[Patel, M. S., Brown, D. A., Wilson, S. E.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Vascular Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.148</dc:identifier>
<dc:title><![CDATA[Relevance of the ADAM and UK Small Aneurysm Trial Data in the Age of Endovascular Aneurysm Repair [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>810</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>806</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/811?rss=1">
<title><![CDATA[Open Abdominal Aortic Aneurysm Repair in the Endovascular Era: Effect of Clamp Site on Outcomes [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/811?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To describe a contemporary series of open abdominal aortic aneurysm (AAA) repairs in patients not anatomically suitable for endovascular AAA repair.</p>
<p><b>Methods&nbsp;</b> A prospectively maintained database including consecutive nonruptured open aneurysm repairs from March 1, 2000, through July 31, 2007, was reviewed. Patient demographic characteristics and perioperative outcomes were evaluated and stratified based on proximal aortic cross-clamp placement.</p>
<p><b>Results&nbsp;</b> A total of 185 patients with AAA underwent 103 infrarenal and 82 suprarenal cross-clamp repairs. Overall, the complication rate was 37.0% with infrarenal and 61.0% with suprarenal cross-clamps (<I>P</I>&nbsp;=&nbsp;.001). The 30-day mortality was 2.9% with infrarenal and 6.1% with suprarenal cross-clamps (<I>P</I>&nbsp;=&nbsp;.18). Postoperative renal insufficiency (29.3% vs 7.8%; <I>P</I>&nbsp;&lt;&nbsp;.001) and pulmonary complications (25.6% vs 12.6%; <I>P</I>&nbsp;=&nbsp;.03) were more frequent with suprarenal cross-clamps. Suprarenal cross-clamps were associated with greater intraoperative blood loss (2586 mL vs 1638 mL; <I>P</I>&nbsp;=&nbsp;.006), operative duration (391 min vs 355 min; <I>P</I>&nbsp;=&nbsp;.005), use of adjunctive renal and/or visceral grafts (43.9% vs 1.9%; <I>P</I>&nbsp;&lt;&nbsp;.001), duration of intensive care unit stay (4.5 days vs 3.0 days; <I>P</I>&nbsp;=&nbsp;.006), and hospital length of stay (9 days vs 7 days; <I>P</I>&nbsp;=&nbsp;.04). Of patients who received a suprarenal cross-clamp, 25.6% required temporary nursing home placement vs 17.5% with an infrarenal cross-clamp (<I>P</I>&nbsp;=&nbsp;.14).</p>
<p><b>Conclusions&nbsp;</b> Until fenestrated and branched endografts are available, open AAA repairs will become increasingly complex. Suprarenal cross-clamping is associated with increased rates of complications but similar mortality rates and need for nursing home placement. With the disappearance of straightforward open aneurysm repair, trainees in vascular surgery will have to learn AAA repair almost exclusively by operating on patients with complex AAAs. Fewer surgeons will perform these repairs, and fewer fellows will be able to complete the operation independently immediately after training.</p>
]]></description>
<dc:creator><![CDATA[Landry, G., Lau, I., Liem, T., Mitchell, E., Moneta, G.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Cardiovascular/ Cardiothoracic Surgery, Endoscopy/ Minimally Invasive Surgery, Vascular Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.157</dc:identifier>
<dc:title><![CDATA[Open Abdominal Aortic Aneurysm Repair in the Endovascular Era: Effect of Clamp Site on Outcomes [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>816</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>811</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/817?rss=1">
<title><![CDATA[Major Blood Vessel Reconstruction During Sarcoma Surgery [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/817?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate the outcomes of major vessel reconstruction as part of surgery to remove sarcomas.</p>
<p><b>Design&nbsp;</b> Retrospective review.</p>
<p><b>Setting&nbsp;</b> Tertiary academic medical center.</p>
<p><b>Patients&nbsp;</b> Fourteen patients (10 female) with retroperitoneal or extremity sarcomas and major blood vessel involvement who underwent surgery to remove the tumor and had blood vessel reconstruction between 2003 and 2008. Each patient underwent computed tomography angiography.</p>
<p><b>Main Outcome Measures&nbsp;</b> Early (&lt;30 days) and late (>30 days) operative morbidity and mortality, freedom from disease, and graft patency.</p>
<p><b>Results&nbsp;</b> Seven patients had retroperitoneal sarcomas and 7, extremity sarcomas. Thirteen tumors were malignant (7 high grade and 6 low grade) and 1, benign (leiomyoma). Seven patients had replacement of artery and vein; 5, artery only; and 2, vein only. In all, 16 arteries were reconstructed (2 common femoral; 5 iliac; 2 superficial femoral; 1 brachial; 1 popliteal; and 2 aorta, one with implantation of both iliac arteries and the other with implantation of the left renal, superior mesenteric, and hepatic arteries). Eight patients (57%) had 9 veins reconstructed (3 external iliac, 3 superficial femoral, 2 vena cava, and 1 popliteal). Primary arterial patency was 58% and primary-assisted patency was 83%. Venous patency was 78%. Local recurrence occurred in 3 patients (21%). Five-year disease-free and overall survival were 52% and 68%, respectively. Limb salvage was achieved in 93%.</p>
<p><b>Conclusion&nbsp;</b> Involvement of vascular structures is not a contraindication for resection of sarcomas, but appropriate planning is necessary to optimize outcome.</p>
]]></description>
<dc:creator><![CDATA[Song, T. K., Harris, E. J., Raghavan, S., Norton, J. A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Surgery, Surgical Interventions, Surgical Oncology, Vascular Surgery, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.149</dc:identifier>
<dc:title><![CDATA[Major Blood Vessel Reconstruction During Sarcoma Surgery [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>822</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>817</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/823?rss=1">
<title><![CDATA[Outcomes of Nissen Fundoplication in Patients With Gastroesophageal Reflux Disease and Delayed Gastric Emptying [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/823?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To investigate the effect of delayed gastric emptying (DGE) on subjective and objective outcomes of gastroesophageal reflux disease following Nissen fundoplication with or without pyloroplasty.</p>
<p><b>Design&nbsp;</b> Retrospective analysis of prospectively collected data.</p>
<p><b>Setting&nbsp;</b> Tertiary care teaching hospital.</p>
<p><b>Patients&nbsp;</b> A total of 141 consecutive patients considered for Nissen fundoplication who also had suspected DGE based on symptoms.</p>
<p><b>Interventions&nbsp;</b> Of 141 patients, 63 had a time to 50% emptying (T1/2)&nbsp;greater than&nbsp;90 minutes; 47 of the 63 of these had severe DGE (T1/2&nbsp;>&nbsp;150 minutes) and had Nissen fundoplication and pyloroplasty. Sixteen of the 141 with T1/2 greater than 90 but less than 150 minutes and 78 with normal gastric emptying findings (n&nbsp;=&nbsp;78) had Nissen fundoplication only.</p>
<p><b>Main Outcome Measures&nbsp;</b> Postoperatively, patients with symptom scores greater than 2 and/or abnormal 24-hour pH values (DeMeester score >14.7) were considered to have had unsuccessful treatment. Gastroesophageal reflux disease outcomes were compared between groups 1 and 2. Finally, the outcomes of both groups were compared with a control cohort of 418 patients with Nissen fundoplication and no DGE symptoms (group 3).</p>
<p><b>Results&nbsp;</b> At the mean follow-up of 21 months, there were no differences between the 2 groups regarding relief of reflux symptoms (DGE group, 54 of 63 [85.7%] vs NGE group, 71 of 78 [91%]; <I>P</I>&nbsp;=&nbsp;.47) or objective control of acid reflux (DGE group, 33 of 39 [84.6%] vs NGE group, 41 of 51 [80.3%]; <I>P</I>&nbsp;=&nbsp;.78). Dyspeptic symptoms were improved in the DGE group (<I>P</I>&nbsp;&lt;&nbsp;.001); however, the overall incidence remained higher than the NGE group (<I>P</I>&nbsp;=&nbsp;.01). Postoperatively, T1/2 normalized in 88.23% (15 of 17) of patients. Postoperative objective outcomes were also no different between these groups and patients with Nissen fundoplication who did not have DGE symptoms (n&nbsp;=&nbsp;418).</p>
<p><b>Conclusions&nbsp;</b> Delayed gastric emptying does not affect outcomes of gastroesophageal reflux disease following Nissen fundoplication, but patients with DGE have more postoperative gas and bloat and/or nausea compared with patients with normal gastric emptying; this is mostly corrected by addition of a pyloroplasty.</p>
]]></description>
<dc:creator><![CDATA[Khajanchee, Y. S., Dunst, C. M., Swanstrom, L. L.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Gastrointestinal/ Upper Foregut, Thoracic Surgery, Prognosis/ Outcomes, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.160</dc:identifier>
<dc:title><![CDATA[Outcomes of Nissen Fundoplication in Patients With Gastroesophageal Reflux Disease and Delayed Gastric Emptying [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>828</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>823</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/829?rss=1">
<title><![CDATA[Lyophilized Plasma for Resuscitation in a Swine Model of Severe Injury [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/829?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Lyophilized plasma (LP) is as safe and effective as fresh frozen plasma (FFP) for resuscitation after severe trauma.</p>
<p><b>Design&nbsp;</b> Multicenter animal study.</p>
<p><b>Setting&nbsp;</b> Animal laboratories, 2 level I trauma centers.</p>
<p><b>Participants&nbsp;</b> Thirty-two Yorkshire crossbred swine.</p>
<p><b>Interventions&nbsp;</b> Lyophilized plasma was analyzed for factor levels and clotting activity before lyophilization and after reconstitution. Swine were subjected to complex multiple trauma including extremity fracture, hemorrhage, severe liver injury, acidosis, and hypothermia. They were then resuscitated with FFP, LP, FFP and packed red blood cells (PRBCs) in a ratio of 1:1, or 1:1 LP and PRBCs.</p>
<p><b>Main Outcome Measures&nbsp;</b> Residual clotting activity of LP after reconstitution, swine mortality, hemodynamic measures, total blood loss, coagulation profiles, and inflammatory measures.</p>
<p><b>Results&nbsp;</b> Lyophilization decreased clotting factor activity by an average of 14%. Survival and heart rate were similar between all groups. Swine resuscitated with LP had equivalent or higher mean arterial pressures. Swine treated with LP had similar coagulation profiles, plasma lactate levels, and postinjury blood loss compared with those treated with FFP. Swine treated with 1:1 FFP-PRBCs were similar to those treated with 1:1 LP-PRBCs. Resuscitation with LP resulted in a reduction in postresuscitation interleukin 6 expression compared with resuscitation with FFP.</p>
<p><b>Conclusions&nbsp;</b> The process of lyophilization and reconstitution of plasma reduces coagulation factor activity by 14%, without acute differences in blood loss. Lyophilized plasma can be used for resuscitation in a severe multiple trauma and hemorrhagic shock swine model with efficacy equal to that of FFP and with decreased interleukin 6 production.</p>
]]></description>
<dc:creator><![CDATA[Spoerke, N., Zink, K., Cho, S. D., Differding, J., Muller, P., Karahan, A., Sondeen, J., Holcomb, J. B., Schreiber, M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Physiology, Blood/ Coagulation]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.154</dc:identifier>
<dc:title><![CDATA[Lyophilized Plasma for Resuscitation in a Swine Model of Severe Injury [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>834</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>829</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/835?rss=1">
<title><![CDATA[Combination of Microsatellite Instability and Lymphocytic Infiltrate as a Prognostic Indicator for Adjuvant Therapy in Colon Cancer [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/835?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Microsatellite instability (MSI) and lymphocytic infiltrate (LI) in colon cancer are associated with less aggressive biological characteristics. Patients with stage II disease who are negative for MSI and LI have been found to have a less favorable prognosis. These patients may be candidates for more aggressive adjuvant therapy.</p>
<p><b>Objective&nbsp;</b> To evaluate the outcomes of patients with colon cancer treated with and without adjuvant chemotherapy on the basis of stage, MSI, and LI.</p>
<p><b>Design&nbsp;</b> Prospective evaluation of MSI and LI status with retrospective analysis of chemotherapy regimen.</p>
<p><b>Setting&nbsp;</b> Community hospital system.</p>
<p><b>Patients&nbsp;</b> A total of 167 patients with colon cancer.</p>
<p><b>Intervention&nbsp;</b> Definitive resection of colorectal cancer with or without chemotherapy.</p>
<p><b>Main Outcome Measure&nbsp;</b> Disease-free survival (DFS) with and without chemotherapy according to combined MSI and LI status.</p>
<p><b>Results&nbsp;</b> Data on MSI and LI status and chemotherapeutic regimens were available for 140 patients. The 5-year DFS was 50% for patients with stage II disease who underwent chemotherapy vs 76% for those who did not (<I>P</I>&nbsp;=&nbsp;.02). In the group negative for MSI and LI, 5-year DFS was 29% for those undergoing chemotherapy and 91% for those who did not (<I>P</I>&nbsp;=&nbsp;.001).</p>
<p><b>Conclusions&nbsp;</b> Forgoing adjuvant chemotherapy should be considered in patients with stage II colon cancer who are negative for MSI and LI. The MSI and LI status shows promise as a combined prognostic marker and may prove particularly useful in selecting patients with stage II disease for adjunctive therapy.</p>
]]></description>
<dc:creator><![CDATA[Kumar, S., Chang, E. Y., Frankhouse, J., Dorsey, P. B., Lee, R. G., Johnson, N.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Colon Cancer, Surgery, Surgical Interventions, Colorectal Surgery, Prognosis/ Outcomes, Drug Therapy, Drug Therapy, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.162</dc:identifier>
<dc:title><![CDATA[Combination of Microsatellite Instability and Lymphocytic Infiltrate as a Prognostic Indicator for Adjuvant Therapy in Colon Cancer [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>840</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>835</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/841?rss=1">
<title><![CDATA[Negligible Effect of Selective Preoperative Biliary Drainage on Perioperative Resuscitation, Morbidity, and Mortality in Patients Undergoing Pancreaticoduodenectomy [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/841?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To examine the effect of selective preoperative biliary drainage (BD) on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy. Biliary drainage prior to pancreaticoduodenectomy remains controversial. Proponents argue that it facilitates referral to high-volume tertiary centers, while detractors maintain that it increases surgical morbidity and mortality.</p>
<p><b>Design&nbsp;</b> Retrospective analysis of single-institution tumor registry database.</p>
<p><b>Setting&nbsp;</b> University medical center.</p>
<p><b>Patients&nbsp;</b> From October 1, 2003, to May 31, 2008, 90 patients underwent pancreaticoduodenectomy for periampullary mass lesions.</p>
<p><b>Main Outcome Measures&nbsp;</b> Clinicopathologic data were reviewed and analyzed among patients who did and did not receive BD for their association with perioperative outcomes. <sup>2</sup> Analysis, independent-samples <I>t</I> tests, and Mann-Whitney <I>U</I> tests were used as appropriate.</p>
<p><b>Results&nbsp;</b> Fifty-six patients (62%) underwent BD, and 34 (38%) did not. Intraoperative bile cultures were positive for 1 or more species of microorganisms in 88% of stented patients (35 of 40). There were no significant differences in fluid requirements, transfusion requirements, or surgery duration between patients who did and did not undergo BD. Estimated blood loss was increased in patients who received BD (625 mL vs 525 mL in patients who did not undergo BD; <I>P</I>&nbsp;=&nbsp;.03), while reoperation was significantly more common in nonstented patients (4% vs 15% in patients who did not undergo BD; <I>P</I>&nbsp;=&nbsp;.02). Intensive care unit stay, overall length of stay, pancreatic leak/abscess/fistula, infectious complications, postoperative percutaneous drainage, hospital readmission, and 30- and 90-day mortality were not significantly different between the 2 groups.</p>
<p><b>Conclusions&nbsp;</b> Although preoperative biliary stents may complicate the intraoperative management and lessen the postoperative complications of patients undergoing pancreaticoduodenectomy, only estimated blood loss and reoperation were significantly different in this cohort. Further study may reveal patient subgroups who may specifically benefit or suffer from preoperative biliary stenting. Currently, selective preoperative BD appears appropriate in the multidisciplinary management of patients with periampullary lesions.</p>
]]></description>
<dc:creator><![CDATA[Coates, J. M., Beal, S. H., Russo, J. E., Vanderveen, K. A., Chen, S. L., Bold, R. J., Canter, R. J.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Oncology, Other, Surgery, Surgical Interventions, Endocrine Surgery, Surgical Oncology, Hepatobiliary Surgery, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.152</dc:identifier>
<dc:title><![CDATA[Negligible Effect of Selective Preoperative Biliary Drainage on Perioperative Resuscitation, Morbidity, and Mortality in Patients Undergoing Pancreaticoduodenectomy [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>847</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>841</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/848?rss=1">
<title><![CDATA[Open Incisional Hernia Repair at an Academic Tertiary Care Medical Center [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/848?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To describe the postoperative complication rates of a large consecutive series of patients who underwent open incisional ventral hernia repair.</p>
<p><b>Design&nbsp;</b> Retrospective medical record review of an accumulated database.</p>
<p><b>Setting&nbsp;</b> University tertiary care medical center.</p>
<p><b>Patients&nbsp;</b> All patients who underwent open incisional ventral hernia repair from March 1, 2003, through February 28, 2008.</p>
<p><b>Intervention&nbsp;</b> Open incisional ventral hernia repair.</p>
<p><b>Main Outcome Measures&nbsp;</b> Postoperative complications, including hernia recurrences.</p>
<p><b>Results&nbsp;</b> A total of 507 cases (465 patients; female to male ratio, 1.1:1) met our criteria; median follow-up was 40 months. In 23.5% of the cases, repair had been attempted previously, and 16.4% had previously undergone organ transplant. The postoperative complication rate was 38.1%. Hernias recurred in 18.9% of cases. Perioperative mortality was 1.0%. Patients undergoing transplant were more likely than those not undergoing transplant to have a hernia recurrence (16.3% vs 32.5%; <I>P</I>&nbsp;&lt;&nbsp;.001) and were equally likely to have a postoperative complication (36.9% vs 44.6%; <I>P</I>&nbsp;=&nbsp;.19). Patients who underwent repair of a recurrent incisional hernia were as likely to have a hernia recurrence as those who underwent initial repair (21.0% vs 18.3%; <I>P</I>&nbsp;=&nbsp;.52) but more likely to have an overall complication (47.9% vs 35.1%; <I>P</I>&nbsp;=&nbsp;.01).</p>
<p><b>Conclusions&nbsp;</b> In this series of incisional hernia repairs at a tertiary care center, the overall recurrence rate of 18.9% is comparable to that of other published series. Ours is the largest published series of recurrent hernias that shows a recurrence rate comparable to that for initial repairs. This outcome may be the result of greater use of more complex repair techniques.</p>
]]></description>
<dc:creator><![CDATA[Mohebali, K., Young, D. M., Hansen, S. L., Shawo, A., Freise, C. E., Chang, D. S., Maa, J., Harris, H. W.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Surgical Interventions, Other, Surgical Physiology, Surgical Physiology, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.161</dc:identifier>
<dc:title><![CDATA[Open Incisional Hernia Repair at an Academic Tertiary Care Medical Center [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>852</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>848</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/853?rss=1">
<title><![CDATA[A Simplified Set of Trauma Triage Criteria to Safely Reduce Overtriage: A Prospective Study [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/853?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Many trauma systems have adopted complex triage algorithms that are difficult to use and contain poorly validated variables.</p>
<p><b>Objective&nbsp;</b> To prospectively evaluate the performance of our institution's current triage system compared with a simplified system using only 4 highly predictive variables.</p>
<p><b>Design, Setting, and Patients&nbsp;</b> A prospective observational study of trauma patients in a 9-month period at an academic level II trauma center was undertaken. All trauma admissions were analyzed for the need for immediate emergency interventions or operative procedures. The accuracy and safety of the current triage system was compared with a simplified triage protocol using only 4 variables (hypotension, mental status, altered respirations, and penetrating truncal wound). Overtriage and undertriage rates were compared, and detailed analysis of all undertriaged patients was performed.</p>
<p><b>Main Outcome Measures&nbsp;</b> Rates of overtriage, undertriage, morbidity, and mortality.</p>
<p><b>Results&nbsp;</b> There were 244 trauma team activations, with 21% requiring urgent intervention. Existing criteria produced an overtriage rate of 79%, an undertriage rate of 1%, and mistriage in 14%. Using the simplified criteria, the overtriage rate was reduced to 12% and the undertriage rate was increased to 4% (both <I>P</I>&nbsp;&lt;&nbsp;.05). Undertriaged patients were all hemodynamically stable, with 4 requiring tube thoracostomy only and 4 undergoing nonemergent laparotomy (2 nontherapeutic laparotomies, 1 bladder repair, and 1 bowel mesenteric injury). There were no deaths among undertriaged patients with either system.</p>
<p><b>Conclusions&nbsp;</b> Using a simplified triage system can safely reduce the rate of overtriage. This could conserve resources, reduce mistriage from misunderstood guidelines, and improve specificity by including only those variables with high predictive value.</p>
]]></description>
<dc:creator><![CDATA[Lehmann, R., Brounts, L., Lesperance, K., Eckert, M., Casey, L., Beekley, A., Martin, M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgery, Other, Emergency Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.153</dc:identifier>
<dc:title><![CDATA[A Simplified Set of Trauma Triage Criteria to Safely Reduce Overtriage: A Prospective Study [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>858</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>853</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/859?rss=1">
<title><![CDATA[Creation of Inpatient Capacity During a Major Hospital Relocation: Lessons for Disaster Planning [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/859?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To identify tools to aid the creation of disaster surge capacity using a model of planned inpatient census reduction prior to relocation of a university hospital.</p>
<p><b>Design&nbsp;</b> Prospective analysis of hospital operations for 1-week periods beginning 2 weeks (baseline) and 1 week (transition) prior to move day; analysis of regional hospital and emergency department capacity.</p>
<p><b>Setting&nbsp;</b> Large metropolitan university teaching hospital.</p>
<p><b>Main Outcome Measures&nbsp;</b> Hospital census figures and patient outcomes.</p>
<p><b>Results&nbsp;</b> Census was reduced by 36% from 537 at baseline to 345 on move day, a rate of 18 patients/d (<I>P</I>&nbsp;&lt;&nbsp;.005). Census reduction was greater for surgical services than nonsurgical services (46% vs 30%; <I>P</I>&nbsp;=&nbsp;.02). Daily volume of elective operations also decreased significantly, while the number of emergency operations was unchanged. Hospital admissions were decreased by 42%, and the adjusted discharges per occupied bed were increased by 8% (both <I>P</I>&nbsp;&lt;&nbsp;.05). Inpatient mortality was not affected. Regional capacity to absorb new patients was limited. During a period in which southern California population grew by 8.5%, acute care beds fell by 3.3%, while Los Angeles County emergency departments experienced a 13% diversion rate due to overcrowding.</p>
<p><b>Conclusions&nbsp;</b> Local or regional disasters of any size can overwhelm the system's ability to respond. Our strategy produced a surge capacity of 36% without interruption of emergency department and trauma services but required 3 to 4 days for implementation, making it applicable to disasters and mass casualty events with longer lead times. These principles may aid in disaster preparedness and planning.</p>
]]></description>
<dc:creator><![CDATA[Jen, H. C., Shew, S. B., Atkinson, J. B., Rosenthal, J. T., Hiatt, J. R.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Medical Practice, Medical Practice, Other, Public Health, Public Health, Other, Surgery, Surgery, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.146</dc:identifier>
<dc:title><![CDATA[Creation of Inpatient Capacity During a Major Hospital Relocation: Lessons for Disaster Planning [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>864</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>859</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/865?rss=1">
<title><![CDATA[Positive Serum Ethanol Level and Mortality in Moderate to Severe Traumatic Brain Injury [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/865?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Ethanol exposure is associated with decreased mortality in patients with moderate to severe traumatic brain injury.</p>
<p><b>Design&nbsp;</b> Retrospective database review.</p>
<p><b>Setting&nbsp;</b> Trauma centers contributing to the National Trauma Data Bank (NTDB).</p>
<p><b>Patients&nbsp;</b> Version 6.2 of the NTDB (2000-2005) was queried for all patients with moderate to severe traumatic brain injury (head Abbreviated Injury Score &ge;3) and ethanol levels measured on admission. Demographics and outcomes were compared between patients with traumatic brain injuries with and without ethanol in their blood. Logistic regression analysis was used to investigate the relationship between mortality and ethanol.</p>
<p><b>Main Outcome Measures&nbsp;</b> Mortality and complications.</p>
<p><b>Results&nbsp;</b> A total of 38&nbsp;019 patients with severe traumatic brain injuries were evaluated. Thirty-eight percent tested positive for ethanol. Ethanol-positive patients were younger (mean [SD], 37.7 [15.1] vs 44.1 [22.0] years, <I>P</I>&nbsp;&lt;&nbsp;.001), had a lower Injury Severity Score (22.3 [10.0] vs 23.0 [10.3], <I>P</I>&nbsp;&lt;&nbsp;.001), and a lower Glasgow Coma Scale score (10.0 [5.1] vs 11.0 [4.9], <I>P</I>&nbsp;&lt;&nbsp;.001) compared with their ethanol-negative counterparts. After logistic regression analysis, ethanol was associated with reduced mortality (adjusted odds ratio, 0.88; 95% confidence interval, 0.80-0.96; <I>P</I>&nbsp;=&nbsp;.005) and higher complications (adjusted odds ratio, 1.24; 95% confidence interval, 1.15-1.33; <I>P</I>&nbsp;&lt;&nbsp;.001).</p>
<p><b>Conclusions&nbsp;</b> Serum ethanol is independently associated with decreased mortality in patients with moderate to severe head injuries. Additional research is warranted to investigate the potential therapeutic implications of this association.</p>
]]></description>
<dc:creator><![CDATA[Salim, A., Ley, E. J., Cryer, H. G., Margulies, D. R., Ramicone, E., Tillou, A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Critical Care/ Intensive Care Medicine, Critical Care Medicine, Other, Public Health, Substance Abuse/ Alcoholism, Surgery, Surgical Interventions, Neurosurgery, Surgical Physiology, Surgical Physiology, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.158</dc:identifier>
<dc:title><![CDATA[Positive Serum Ethanol Level and Mortality in Moderate to Severe Traumatic Brain Injury [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>871</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>865</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/872?rss=1">
<title><![CDATA[Use of Wound-Protection System and Postoperative Wound-Infection Rates in Open Appendectomy: A Randomized Prospective Trial [Poster Session]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/872?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To determine if use of a wound-protection system in open appendectomy decreases the rate of wound infection.</p>
<p><b>Design&nbsp;</b> A randomized prospective trial.</p>
<p><b>Setting&nbsp;</b> A community hospital.</p>
<p><b>Patients&nbsp;</b> One hundred nine patients undergoing open appendectomy.</p>
<p><b>Intervention&nbsp;</b> Randomly assigned conventional retraction or retraction with the wound-protection system. Patients were blinded to the study arm in which they were enrolled. All patients were given standardized preoperative antibiotics. Demographics including age, sex, body mass index, history of diabetes, and tobacco use were recorded. The severity of appendicitis as determined by the attending surgeon at the time of operation was also noted.</p>
<p><b>Main Outcome Measures&nbsp;</b> Incidence of wound infection at 21 days postoperatively.</p>
<p><b>Results&nbsp;</b> Of the 48 patients enrolled in the traditional retraction arm, there were 7 (14.6%) documented wound infections. Of the 61 patients enrolled in the wound-protection device arm, there was 1 (1.6%) wound infection. The severity of appendicitis between the 2 groups was matched. The decrease in incidence of wound infection observed with the wound-protection system was significant (<I>P</I>&nbsp;=&nbsp;.02).</p>
<p><b>Conclusion&nbsp;</b> Use of a wound-protection system reduces the incidence of surgical wound infection in open appendectomy.</p>
<p><b>Trial Registration&nbsp;</b> clinicaltrials.gov Identifier: <inter-ref locator-type="url" locator="http://clinicaltrials.gov/show/NCT00323453">NCT00323453</inter-ref></p>
]]></description>
<dc:creator><![CDATA[Lee, P., Waxman, K., Taylor, B., Yim, S.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Gastrointestinal/ Upper Foregut, Surgical Physiology, Surgical Infections]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.151</dc:identifier>
<dc:title><![CDATA[Use of Wound-Protection System and Postoperative Wound-Infection Rates in Open Appendectomy: A Randomized Prospective Trial [Poster Session]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>875</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>872</prism:startingPage>
<prism:section>Poster Session</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/877?rss=1">
<title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/877?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Rottman, S. J., Podolsky, E. R., Mouhlas, A. L., Lerner, K., Pavlides, C.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endocrine Surgery, Diagnosis, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.155-a</dc:identifier>
<dc:title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>877</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>877</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/9/878?rss=1">
<title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/9/878?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:19 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endocrine Surgery, Diagnosis, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.155-b</dc:identifier>
<dc:title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>878</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>878</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/704?rss=1">
<title><![CDATA[About This Journal [About This Journal]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/704?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:37 PDT</dc:date>
<dc:title><![CDATA[About This Journal [About This Journal]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>704</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>704</prism:startingPage>
<prism:section>About This Journal</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/706?rss=1">
<title><![CDATA[Effect Size Estimation: A Necessary Component of Statistical Analysis [Editorial]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/706?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Livingston, E. H., Elliot, A., Hynan, L., Cao, J.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Lung Cancer, Public Health, Tobacco, Pulmonary Diseases, Pulmonary Diseases, Other, Statistics and Research Methods, Surgery, Surgical Interventions, Bariatric Surgery, Surgery, Other, Prognosis/ Outcomes, Diet, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.150</dc:identifier>
<dc:title><![CDATA[Effect Size Estimation: A Necessary Component of Statistical Analysis [Editorial]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>712</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>706</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/713?rss=1">
<title><![CDATA[Patient and Hospital Characteristics on the Variance of Perioperative Outcomes for Pancreatic Resection in the United States: A Plea for Outcome-Based and Not Volume-Based Referral Guidelines [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/713?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> There is an effect of patient and hospital characteristics on perioperative outcomes for pancreatic resection in the United States.</p>
<p><b>Design&nbsp;</b> Retrospective cohort study.</p>
<p><b>Setting&nbsp;</b> Academic research.</p>
<p><b>Patients&nbsp;</b> Patient data from the Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project from January 1988 to January 2003.</p>
<p><b>Main Outcome Measures&nbsp;</b> In-hospital mortality, perioperative complications, and mortality following a major complication.</p>
<p><b>Results&nbsp;</b> A total of 103&nbsp;222 patients underwent major pancreatic surgery. The annual number of pancreatic resections increased 15.0% during the 16-year study period. Resection for benign pancreatic disease increased 26.8%. Overall in-hospital mortality, perioperative complications, and mortality following a major complication were 6.5%, 35.6%, and 15.6%, respectively. Multivariate analysis demonstrated that significant independent predictors for these 3 perioperative outcomes were advancing age, male sex, medical comorbidity, and hospital volume for each type of pancreatic resection. The in-hospital mortality for pancreatoduodenectomy increases with age and ranges from 1.7% to 13.8% (<I>P</I>&nbsp;&lt;&nbsp;.001). After adjusting for other confounders, the odds of in-hospital mortality for pancreatoduodenectomy, distal pancreatectomy, and total pancreatectomy in those 65 years or older were 4.78-fold, 3.84-fold, and 2.60-fold, respectively, lower in the high-volume hospitals compared with those in the lower-volume hospitals.</p>
<p><b>Conclusions&nbsp;</b> Perioperative complications derived from this population-based study were higher than those reported in many case series. A significant disparity was noted in perioperative outcomes among surgical centers across the United States. An outcome-based referral guideline may have an immediate effect on improving the quality of care in patients who undergo pancreatic resection for benign and malignant disease.</p>
]]></description>
<dc:creator><![CDATA[Teh, S. H., Diggs, B. S., Deveney, C. W., Sheppard, B. C.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endocrine Surgery, Surgical Oncology, Prognosis/ Outcomes, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.67</dc:identifier>
<dc:title><![CDATA[Patient and Hospital Characteristics on the Variance of Perioperative Outcomes for Pancreatic Resection in the United States: A Plea for Outcome-Based and Not Volume-Based Referral Guidelines [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>721</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>713</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/721?rss=1">
<title><![CDATA[Patient and Hospital Characteristics on the Variance of Perioperative Outcomes for Pancreatic Resection in the United States--Invited Critique [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/721?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Farnell, M. B.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endocrine Surgery, Surgical Oncology, Prognosis/ Outcomes, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.21</dc:identifier>
<dc:title><![CDATA[Patient and Hospital Characteristics on the Variance of Perioperative Outcomes for Pancreatic Resection in the United States--Invited Critique [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>721</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>721</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/722?rss=1">
<title><![CDATA[Correlation of Microsatellite Instability at Multiple Loci With Long-term Survival in Advanced Gastric Carcinoma [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/722?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Microsatellite instability (MSI) correlates with clinicopathologic characteristics and long-term prognosis in patients having gastric carcinoma.</p>
<p><b>Design&nbsp;</b> Analysis of prospectively collected data and biologic material.</p>
<p><b>Setting&nbsp;</b> Tertiary University Hospital, Policlinico "Le Scotte," Siena, Italy.</p>
<p><b>Patients&nbsp;</b> Two hundred fifty patients with gastric carcinoma.</p>
<p><b>Main Outcome Measures&nbsp;</b> Five mononucleotide repeats (BAT-26, BAT-25, NR-24, NR-21, and NR-27) were analyzed in these patients.</p>
<p><b>Results&nbsp;</b> An MSI phenotype was identified in 63 patients (25.2%) and correlated with specific clinicopathologic characteristics. Favorable prognosis was confirmed for patients with an MSI phenotype in univariate (<I>P</I>&nbsp;&lt;&nbsp;.001) and multivariate (<I>P</I>&nbsp;=&nbsp;.05) analyses. Significant differences in clinicopathologic characteristics and long-term prognoses were observed among patients with microsatellite-stable tumors, tumors having instability at 2 to 4 markers, and tumors having instability at all 5 markers (MSI/5). The MSI/5 phenotype was associated with older age (<I>P</I>&nbsp;&lt;&nbsp;.001), female sex (<I>P</I>&nbsp;=&nbsp;.001), antral tumor location (<I>P</I>&nbsp;=&nbsp;.04), intestinal histotype (<I>P</I>&nbsp;=&nbsp;.003), and less infiltration of the serosa (<I>P</I>&nbsp;=&nbsp;.006); lymph node involvement was rare (<I>P</I>&nbsp;&lt;&nbsp;.001) and was limited to few (median, 3) metastatic lymph nodes (<I>P</I>&nbsp;=&nbsp;.001). Long-term survival of patients with the MSI/5 phenotype is favorable and was confirmed in multivariate analysis (relative risk vs patients with stable tumors, 0.32; 95% confidence interval, 0.16-0.63; <I>P</I>&nbsp;=&nbsp;.002).</p>
<p><b>Conclusions&nbsp;</b> Compared with stable tumors, MSI tumors have distinct clinicopathologic features and are associated with a better prognosis. Patients with the MSI/5 phenotype have a very good prognosis.</p>
]]></description>
<dc:creator><![CDATA[Corso, G., Pedrazzani, C., Marrelli, D., Pascale, V., Pinto, E., Roviello, F.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Surgical Oncology, Surgical Physiology, Surgical Physiology, Other, Prognosis/ Outcomes, Gastroenterology, Gastrointestinal Diseases, Genetics, Genetic Counseling/ Testing/ Therapy]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.42</dc:identifier>
<dc:title><![CDATA[Correlation of Microsatellite Instability at Multiple Loci With Long-term Survival in Advanced Gastric Carcinoma [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>727</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>722</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/727?rss=1">
<title><![CDATA[Correlation of Microsatellite Instability at Multiple Loci With Long-term Survival in Advanced Gastric Carcinoma--Invited Critique [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/727?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Zenilman, M. E.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Surgical Oncology, Surgical Physiology, Surgical Physiology, Other, Prognosis/ Outcomes, Gastroenterology, Gastrointestinal Diseases, Genetics, Genetic Counseling/ Testing/ Therapy]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.26</dc:identifier>
<dc:title><![CDATA[Correlation of Microsatellite Instability at Multiple Loci With Long-term Survival in Advanced Gastric Carcinoma--Invited Critique [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>727</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>727</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/728?rss=1">
<title><![CDATA[Type D Personality and Mortality in Peripheral Arterial Disease: A Pilot Study [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/728?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Type D personality refers to the tendency to experience negative emotions and to inhibit self-expression in social interaction and has been shown to be an independent predictor of mortality in cardiac disease. Information about the effects of psychological traits on prognosis is lacking in cases of peripheral arterial disease (PAD).</p>
<p><b>Objective&nbsp;</b> To examine whether type D personality predicts all-cause mortality in PAD.</p>
<p><b>Design&nbsp;</b> Pilot follow-up study.</p>
<p><b>Setting&nbsp;</b> Vascular surgery department of a teaching hospital.</p>
<p><b>Patients&nbsp;</b> A total of 184 patients with symptomatic PAD (mean [SD] age, 64.8 [9.8] years) were followed up for 4 years (interquartile range, 3.5-4.5 years).</p>
<p><b>Main Outcome Measures&nbsp;</b> Patients completed the type D Scale-14 measure of type D personality at baseline. Information about all-cause mortality was obtained from patient medical files.</p>
<p><b>Results&nbsp;</b> During 4-year follow-up, 16 patients (8.7%) died. Adjusting for age and sex, type D personality was predictive of mortality (<I>P</I>&nbsp;=&nbsp;.03). Ankle-brachial index (<I>P</I>&nbsp;=&nbsp;.05), age (<I>P</I>&nbsp;=&nbsp;.009), diabetes mellitus (<I>P</I>&nbsp;=&nbsp;.02), pulmonary disease (<I>P</I>&nbsp;=&nbsp;.09), and renal disease (<I>P</I>&nbsp;=&nbsp;.02) were also predictive of mortality. Multivariable logistic regression revealed that age, diabetes, and renal disease were independent predictors of all-cause mortality (odds ratios, 1.1-2.3). After adjustment for these clinical predictors, patients with type D personality still had a more than 3-fold increased risk of death (odds ratio, 3.5; 95% confidence interval, 1.1-11.1; <I>P</I>&nbsp;=&nbsp;.04).</p>
<p><b>Conclusions&nbsp;</b> Type D personality predicts an increased risk of all-cause mortality in PAD, above and beyond traditional risk factors. Further research is needed to confirm these findings, but this pilot study suggests that the assessment of type D personality may be useful for detecting high-risk patients with PAD.</p>
]]></description>
<dc:creator><![CDATA[Aquarius, A. E., Smolderen, K. G., Hamming, J. F., De Vries, J., Vriens, P. W., Denollet, J.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Patient-Physician Relationship/ Care, Psychosocial Issues, Psychiatry, Stress, Cardiovascular System, Surgery, Surgical Interventions, Vascular Surgery, Prognosis/ Outcomes, Cardiovascular Disease/ Myocardial Infarction]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.75</dc:identifier>
<dc:title><![CDATA[Type D Personality and Mortality in Peripheral Arterial Disease: A Pilot Study [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>733</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>728</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/733?rss=1">
<title><![CDATA[Type D Personality and Mortality in Peripheral Arterial Disease--Invited Critique [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/733?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Illig, K. A.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Patient-Physician Relationship/ Care, Psychosocial Issues, Psychiatry, Stress, Cardiovascular System, Surgery, Surgical Interventions, Vascular Surgery, Prognosis/ Outcomes, Cardiovascular Disease/ Myocardial Infarction]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.76</dc:identifier>
<dc:title><![CDATA[Type D Personality and Mortality in Peripheral Arterial Disease--Invited Critique [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>733</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>733</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/734?rss=1">
<title><![CDATA[Single-Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/734?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To describe our experience with a single-incision laparoscopic cholecystectomy (SILC) performed using a flexible endoscope as the means of visualization and surgical dissection. The use of flexible endoscopy in intra-abdominal surgery has never been described.</p>
<p><b>Design&nbsp;</b> Prospective observational case series.</p>
<p><b>Patients&nbsp;</b> Eleven patients with symptomatic cholelithiasis were selected based on age, clinical presentation, body habitus, and history of previous abdominal surgery. Patients with acute or chronic cholecystitis were excluded.</p>
<p><b>Results&nbsp;</b> All procedures were completed laparoscopically via the single umbilical incision without the need to convert to an open operation and without introduction of any additional laparoscopic instruments or trocars. The mean operative time was 149.5 minutes (range, 99-240 minutes). The mean length of hospital stay was 0.36 days. There were no associated intraoperative or postoperative complications.</p>
<p><b>Conclusions&nbsp;</b> In our experience, SILC performed with a flexible endoscope is feasible and safe. Further studies are needed to determine its advantages in reference to postoperative pain and complication rate in juxtaposition with the current standard laparoscopic cholecystectomy.</p>
]]></description>
<dc:creator><![CDATA[Binenbaum, S. J., Teixeira, J. A., Forrester, G. J., Harvey, E. J., Afthinos, J., Kim, G. J., Koshy, N., McGinty, J., Belsley, S. J., Todd, G. J.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:identifier>info:doi/10.1001/archsurg.2009.129</dc:identifier>
<dc:title><![CDATA[Single-Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>738</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>734</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/738?rss=1">
<title><![CDATA[Single-Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope--Invited Critique [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/738?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Livingston, E. H.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Endoscopy of Upper Aerodigestive Tract, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Hepatobiliary Surgery, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.130</dc:identifier>
<dc:title><![CDATA[Single-Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope--Invited Critique [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>739</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>738</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/740?rss=1">
<title><![CDATA[Mesh-Reinforced Ventral Hernia Repair: Preference for 2 Techniques [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/740?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Long-term (5-year) recurrence rates are comparable between onlay vs retrorectus mesh-reinforced ventral hernia repairs.</p>
<p><b>Design&nbsp;</b> Retrospective study of prospective data collection.</p>
<p><b>Setting&nbsp;</b> University and Veterans Affairs hospitals.</p>
<p><b>Patients&nbsp;</b> One hundred twenty-five patients treated between February 1988 and September 2001. Ninety-four patients were male. The mean patient age was 56 years (age range, 29-80 years). Fifty percent of patients were smokers, and 32.0% were obese; comorbidities were similar in the 2 cohorts studied.</p>
<p><b>Interventions&nbsp;</b> Open surgical extraperitoneal prosthetic mesh reinforcement of the incisional closure among 75 patients (onlay repair [cohort OR]) or in the retrorectus position among 50 patients (retrorectus repair [cohort RR]).</p>
<p><b>Main Outcome Measures&nbsp;</b> Recurrent hernia, wound infection, and intestinal fistulas.</p>
<p><b>Results&nbsp;</b> Nine patients in cohort OR and 2 patients in cohort RR (8.8%) had wound infections; no fistulas occurred. Complications were similar in the 2 cohorts. One mortality occurred. All hernias recurred at the cranial or caudal edge of the mesh. The median recurrence rates were 20.0% at 15 months in the OR cohort and 4.0% at 9 months in cohort RR (<I>P</I>&nbsp;&lt;&nbsp;.02). Follow-up periods averaged 64 months. Three other patients in cohort OR developed subsequent hernia adjacent to their mesh reinforcement at 72, 73, and 86 months.</p>
<p><b>Conclusions&nbsp;</b> Extraperitoneal mesh reinforcement avoids intestinal complications and subsequent operations to remove mesh. Recurrence is more frequent after onlay mesh reinforcement and usually occurs at the cranial or caudal edge of the mesh within the first 2 years after hernia repair. Retrorectus repair is the preferred open surgical treatment of incisional hernia, but it has not been universally applicable. Hernias developing 6 to 7 years after surgery are not the result of failed earlier repairs.</p>
]]></description>
<dc:creator><![CDATA[Gleysteen, J. J.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.118</dc:identifier>
<dc:title><![CDATA[Mesh-Reinforced Ventral Hernia Repair: Preference for 2 Techniques [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>745</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>740</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/745?rss=1">
<title><![CDATA[Mesh-Reinforced Ventral Hernia Repair--Invited Critique [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/745?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Neumayer, L. A.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.94</dc:identifier>
<dc:title><![CDATA[Mesh-Reinforced Ventral Hernia Repair--Invited Critique [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>745</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>745</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/746?rss=1">
<title><![CDATA[Use of Board Certification and Recertification in Hospital Privileging: Policies for General Surgeons, Surgical Specialists, and Nonsurgical Subspecialists [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/746?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To better understand the relationship between board certification and credentialing policies for surgeons and nonsurgical subspecialists and to examine possible variation in use of board certification among different types of hospitals.</p>
<p><b>Design, Setting, and Participants&nbsp;</b> Telephone survey conducted from November 14, 2006, through March 16, 2007, of the privileging personnel among a random sample of 235 nonchildren's hospitals stratified by teaching status, bed size, metropolitan statistical area, system affiliation, and tax status.</p>
<p><b>Main Outcome Measures&nbsp;</b> Proportion of hospitals that require specialty board certification to gain privileges and hospital requirements for recertification.</p>
<p><b>Results&nbsp;</b> Of 235 hospitals, 11 were ineligible and 183 completed the telephone interview, resulting in an overall response rate of 82%. Approximately one-third of hospitals did not require surgeons and nonsurgical subspecialists ever to be board certified to receive hospital privileges. Among the 109 hospitals that required certification at some point, only 5 (5%) required surgeons and 3 (3%) required nonsurgical subspecialists to be board certified at the point of initial privileging. More than three-fourths of hospitals had exceptions to their certification policies for surgeons and 84 (77%) had them for nonsurgical subspecialists. Eighty-two percent of all hospitals and two-thirds of hospitals whose policies required recertification allowed surgeons and nonsurgical subspecialists to retain privileges when their board certification expired.</p>
<p><b>Conclusion&nbsp;</b> Most hospitals do not consistently use board certification to ensure physician competence at their institutions.</p>
]]></description>
<dc:creator><![CDATA[Freed, G. L., Dunham, K. M., Singer, D.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Patient Safety/ Medical Error, Quality of Care, Other, Surgery, Surgery, Other, Maintenance of Certification Theme Issue]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.28</dc:identifier>
<dc:title><![CDATA[Use of Board Certification and Recertification in Hospital Privileging: Policies for General Surgeons, Surgical Specialists, and Nonsurgical Subspecialists [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>752</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>746</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/752?rss=1">
<title><![CDATA[Use of Board Certification and Recertification in Hospital Privileging--Invited Critique [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/752?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Britt, L. D.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Patient Safety/ Medical Error, Quality of Care, Other, Surgery, Surgery, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.27</dc:identifier>
<dc:title><![CDATA[Use of Board Certification and Recertification in Hospital Privileging--Invited Critique [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>752</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>752</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/753?rss=1">
<title><![CDATA[Health Plan Use of Board Certification and Recertification of Surgeons and Nonsurgical Subspecialists in Contracting Policies [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/753?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To characterize the role of board certification in general surgeon, surgical specialist, and nonsurgical subspecialist credentialing and contracting policies and to examine possible variation among different types of health plans.</p>
<p><b>Design&nbsp;</b> Telephone survey conducted from October 27, 2006, through March 30, 2007.</p>
<p><b>Setting&nbsp;</b> Health plans across the United States.</p>
<p><b>Participants&nbsp;</b> Health plan credentialing personnel from a random sample of 223 health plans stratified by enrollment size, plan type, Medicaid enrollment, and tax status.</p>
<p><b>Main Outcome Measures&nbsp;</b> Proportion of health plans that require specialty board certification at initial contract or at some point during association with the plan and health plan requirements for recertification.</p>
<p><b>Results&nbsp;</b> Of 223 health plans, 9 were ineligible, and credentialing personnel completed the telephone survey in 176, which resulted in an overall response rate of 82%. More than 60% of the health plans in this study did not require surgical specialists, general surgeons, or nonsurgical subspecialists ever to be board certified to contract with the plan. Approximately two-thirds of respondents reported that they did not require surgeons (65%) or nonsurgical subspecialists (63%) with time-limited board certification to recertify in their specialty. More than half of the health plans reported that they made exceptions to their board certification policies based on geographic or network need.</p>
<p><b>Conclusions&nbsp;</b> Most health plans did not use specialty board certification to assess surgeon and nonsurgical subspecialist competence.</p>
]]></description>
<dc:creator><![CDATA[Freed, G. L., Dunham, K. M., Singer, D.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Quality of Care, Other, Surgery, Surgery, Other, Maintenance of Certification Theme Issue]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.128</dc:identifier>
<dc:title><![CDATA[Health Plan Use of Board Certification and Recertification of Surgeons and Nonsurgical Subspecialists in Contracting Policies [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>758</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>753</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/759?rss=1">
<title><![CDATA[Surgeon- and System-Based Influences on Trauma Mortality [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/759?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> The mechanism by which trauma systems improve mortality is unknown. Outcomes may be influenced by experienced trauma surgeons treating more patients (surgeon effect) or improving the overall system of care (system effect). We hypothesized that mortality is lower in patients treated by a fellowship-trained senior trauma program director (experienced) vs first-year general surgery attending surgeon (novice) and that patient mortality for novice surgeons would improve after adding a new senior trauma director.</p>
<p><b>Design&nbsp;</b> Retrospective cohort study.</p>
<p><b>Setting&nbsp;</b> Academic level I trauma center.</p>
<p><b>Patients&nbsp;</b> Individuals who had experienced trauma.</p>
<p><b>Main Outcome Measures&nbsp;</b> We concurrently compared mortality in trauma patients treated by an experienced trauma surgeon with those admitted by novice surgeons during 51/2 years. We also compared mortality in patients treated by novice surgeons before vs after implementation of a more structured trauma program. The <sup>2</sup> test and multiple logistic regression analysis were used to compare the groups. Odds ratios (95% confidence intervals) for death were examined.</p>
<p><b>Results&nbsp;</b> Concurrent comparison of patients treated by novice surgeons vs experienced trauma surgeons demonstrated no difference in mortality (odds ratio, 1.33; 95% confidence interval, 0.82-2.15). At unadjusted univariate analysis, mortality in patients treated by novice surgeons significantly improved over time in the blunt trauma group and all emergency department survivor subgroups. Multivariate analysis demonstrated significantly improved mortality over time in patients treated by novice surgeons (odds ratio, 0.56; 95% confidence interval, 0.37-0.85).</p>
<p><b>Conclusions&nbsp;</b> In a structured trauma program, there is no mortality difference between novice surgeons and their experienced trauma director. The organized trauma program and senior surgical mentoring overpower any influence of individual surgeon inexperience.</p>
]]></description>
<dc:creator><![CDATA[Haut, E. R., Chang, D. C., Hayanga, A. J., Efron, D. T., Haider, A. H., Cornwell, E. E.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Medical Practice, Medical Education, Quality of Care, Quality of Care, Other, Surgery, Surgical Interventions, Surgical Interventions, Other, Surgery, Other, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.100</dc:identifier>
<dc:title><![CDATA[Surgeon- and System-Based Influences on Trauma Mortality [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>764</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>759</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/764?rss=1">
<title><![CDATA[Surgeon- and System-Based Influences on Trauma Mortality--Invited Critique [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/764?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Feliciano, D. V.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Medical Practice, Medical Education, Quality of Care, Quality of Care, Other, Surgery, Surgical Interventions, Surgical Interventions, Other, Surgery, Other, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.93</dc:identifier>
<dc:title><![CDATA[Surgeon- and System-Based Influences on Trauma Mortality--Invited Critique [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>765</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>764</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/766?rss=1">
<title><![CDATA[Value of Routine Postoperative Gastrographin Contrast Swallow Studies After Laparoscopic Gastric Banding [Original Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/766?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Laparoscopic adjustable gastric banding (LAGB) effectively treats morbid obesity and yields improved quality of life with low morbidity and mortality rates. The current standard of care is to perform a postoperative gastrographin study. This study evaluated a series of patients to determine the usefulness of this routine procedure.</p>
<p><b>Design&nbsp;</b> Retrospective analysis.</p>
<p><b>Setting&nbsp;</b> Texas Tech University Health Sciences Center, Lubbock.</p>
<p><b>Patients&nbsp;</b> A series of 100 patients who had undergone LAGB between August 1, 2006, and February 28, 2007, were evaluated by medical record review and a blinded examination of the upper gastrointestinal tract.</p>
<p><b>Main Outcome Measures&nbsp;</b> Laboratory test results and patient vital signs.</p>
<p><b>Results&nbsp;</b> The mean age of the patients was 42 years. The mean initial body mass index (calculated as weight in kilograms divided by height in meters squared) was 50.0. Median excess weight loss was 49.0% after 12 months. Three patients did not undergo gastrographin studies because of a history of allergic reactions to the dye. No differences between the opinion of the surgeon and that of the original radiologist were uncovered. The 97 patients who underwent gastrographin studies lacked leaks; the only radiologic abnormalities were slow passage and reflux in 23 patients. No alteration in patient care resulted. The total cost for the 97 patients was $49&nbsp;470. The 95% confidence interval for 0 useful results for 97 studies is 0.00 to 0.03; at best, 3.2% of patients undergoing this expensive study would have garnered some benefit.</p>
<p><b>Conclusion&nbsp;</b> Routine postoperative upper gastrointestinal tract studies are expensive and of limited value. Instead of relying on them to detect leaks, which are extremely rare after LAGB, reliance should be given to the presence or absence of tachypnea and tachycardia, as is currently done for Roux-en-Y gastric bypass. In this way there will be a cost savings and the potential to make LAGB a same-day procedure.</p>
]]></description>
<dc:creator><![CDATA[Frezza, E. E., Mammarappallil, J. G., Witt, C., Wei, C., Wachtel, M. S.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Public Health, Obesity, Surgery, Surgical Interventions, Bariatric Surgery, Gastrointestinal/ Upper Foregut]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.138</dc:identifier>
<dc:title><![CDATA[Value of Routine Postoperative Gastrographin Contrast Swallow Studies After Laparoscopic Gastric Banding [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>769</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>766</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/769?rss=1">
<title><![CDATA[Author Added to Byline in: Changes in the Use of Carotid Revascularization Among the Medicare Population [Correction]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/769?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Aging/ Geriatrics, Surgery, Surgical Interventions, Vascular Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.156</dc:identifier>
<dc:title><![CDATA[Author Added to Byline in: Changes in the Use of Carotid Revascularization Among the Medicare Population [Correction]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>769</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>769</prism:startingPage>
<prism:section>Correction</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/770?rss=1">
<title><![CDATA[Mortality After Endovascular Repair of Ruptured Abdominal Aortic Aneurysms: A Systematic Review and Meta-analysis [Review Article]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/770?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To document mortality after endovascular repair of ruptured abdominal aortic aneurysms (RAAAs).</p>
<p><b>Data Sources&nbsp;</b> MEDLINE and EMBASE databases.</p>
<p><b>Study Selection&nbsp;</b> Articles that reported data on mortality after endovascular repair of RAAAs were identified. Only patients with true ruptures were included. Additionally, information on mortality after concurrent open repair was sought.</p>
<p><b>Data Extraction&nbsp;</b> One of the authors reviewed all of the studies and extracted appropriate data. A total of 43 articles were identified, 14 of which were excluded.</p>
<p><b>Data Synthesis&nbsp;</b> Twenty-nine articles with 897 patients who underwent endovascular repair met the inclusion criteria. Of the patients with available information, 86% were men; 29% had been operated on under local anesthesia; 28% were hemodynamically unstable; 17% required intra-aortic balloon occlusion; 48% received bifurcated stent grafts; 6% had endovascular procedures converted to open repair intraoperatively; and 5.5% developed abdominal compartment syndrome. In-hospital and/or 30-day mortality ranged between 0% and 54% in different series, whereas the pooled mortality after endovascular repair was 24.5% (95% confidence interval [CI], 19.8%-29.4%). In 19 studies reporting results of both endovascular and concurrent open repair from the same unit, the pooled mortality after open repair was 44.4% (95% CI, 40.0%-48.8%), and the pooled overall mortality for RAAA undergoing endovascular or open repair was 35% (95% CI, 30%-41%).</p>
<p><b>Conclusions&nbsp;</b> Endovascular repair of RAAAs is associated with acceptable mortality rates. Additional studies will be required to verify these promising results and precisely define the role of endovascular treatment as an additional therapeutic option for RAAAs.</p>
]]></description>
<dc:creator><![CDATA[Karkos, C. D., Harkin, D. W., Giannakou, A., Gerassimidis, T. S.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Evidence-Based Medicine, Surgery, Surgical Interventions, Cardiovascular/ Cardiothoracic Surgery, Vascular Surgery, Surgical Physiology, Blood/ Coagulation, Review]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.132</dc:identifier>
<dc:title><![CDATA[Mortality After Endovascular Repair of Ruptured Abdominal Aortic Aneurysms: A Systematic Review and Meta-analysis [Review Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>778</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>770</prism:startingPage>
<prism:section>Review Article</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/778?rss=1">
<title><![CDATA[Mortality After Endovascular Repair of Ruptured Abdominal Aortic Aneurysms--Invited Critique [Invited Critique]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/778?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Black, J. H.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Quality of Care, Evidence-Based Medicine, Surgery, Surgical Interventions, Cardiovascular/ Cardiothoracic Surgery, Vascular Surgery, Surgical Physiology, Blood/ Coagulation, Review]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.133</dc:identifier>
<dc:title><![CDATA[Mortality After Endovascular Repair of Ruptured Abdominal Aortic Aneurysms--Invited Critique [Invited Critique]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>779</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>778</prism:startingPage>
<prism:section>Invited Critique</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/779?rss=1">
<title><![CDATA[Errors in Tables and Figure in: Outcomes Following Thyroid and Parathyroid Surgery in Pregnant Women [Correction]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/779?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Medical Practice, Medical Practice, Other, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Quality of Care, Patient Safety/ Medical Error, Surgery, Surgical Interventions, Endocrine Surgery, Surgical Oncology, Women's Health, Pregnancy and Breast Feeding, Prognosis/ Outcomes, Disparities in Health Care Theme Issue, Endocrine Diseases, Thyroid/ Parathyroid Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.145</dc:identifier>
<dc:title><![CDATA[Errors in Tables and Figure in: Outcomes Following Thyroid and Parathyroid Surgery in Pregnant Women [Correction]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>779</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>779</prism:startingPage>
<prism:section>Correction</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/780?rss=1">
<title><![CDATA[Methamphetamine Colitis: A Rare Case of Ischemic Colitis in a Young Patient [Resident's Forum]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/780?rss=1</link>
<description><![CDATA[
<p>Worldwide, methamphetamine (ie, "crystal meth") abuse is increasing, and is especially prevalent in rural America. However, ischemic colitis secondary to methamphetamine abuse has rarely been reported. We describe the case of a young man who presented with signs and symptoms suggestive of ischemic colitis.</p>
]]></description>
<dc:creator><![CDATA[Holubar, S. D., Hassinger, J. P., Dozois, E. J., Masuoka, H. C.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Public Health, Substance Abuse/ Alcoholism, Surgery, Surgical Interventions, Gastrointestinal/ Upper Foregut, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.139</dc:identifier>
<dc:title><![CDATA[Methamphetamine Colitis: A Rare Case of Ischemic Colitis in a Young Patient [Resident's Forum]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>782</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>780</prism:startingPage>
<prism:section>Resident's Forum</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/783?rss=1">
<title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/783?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Caprino, P., Ridolfini, M. P., Berardi, S., Sofo, L., D'Ugo, D.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Oncology, Other, Surgery, Surgical Interventions, Surgical Oncology, Hepatobiliary Surgery, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases, Hematology/ Hematologic Malignancies, Leukemias/ Lymphomas, Immunology, Immunologic Disorders]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.131-a</dc:identifier>
<dc:title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>783</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>783</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/784?rss=1">
<title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/784?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Oncology, Other, Surgery, Surgical Interventions, Surgical Oncology, Hepatobiliary Surgery, Gastroenterology, Liver/ Biliary Tract/ Pancreatic Diseases, Hematology/ Hematologic Malignancies, Leukemias/ Lymphomas, Immunology, Immunologic Disorders]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.131-b</dc:identifier>
<dc:title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>784</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>784</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/785?rss=1">
<title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/785?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Coughlin, L. M., Hashmi, Z. A., Marx, R. J.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endocrine Surgery, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.136-a</dc:identifier>
<dc:title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>785</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>785</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/786?rss=1">
<title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/786?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Endocrine Surgery, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.136-b</dc:identifier>
<dc:title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>786</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>786</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/787?rss=1">
<title><![CDATA[Test Before You Stop [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/787?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kumar, A., Roberts, D. H.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Cardiovascular System, Surgery, Surgical Physiology, Blood/ Coagulation, Cardiovascular Disease/ Myocardial Infarction, Drug Therapy, Adverse Effects, Genetics, Genetic Counseling/ Testing/ Therapy]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.142</dc:identifier>
<dc:title><![CDATA[Test Before You Stop [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>787</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>787</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/8/787-a?rss=1">
<title><![CDATA[Test Before You Stop--Reply [Correspondence]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/8/787-a?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[O'Riordan, J. M., Margey, R. J., Blake, G., O'Connell, P. R.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:38 PDT</dc:date>
<dc:subject><![CDATA[Cardiovascular System, Surgery, Surgical Physiology, Blood/ Coagulation, Cardiovascular Disease/ Myocardial Infarction, Drug Therapy, Adverse Effects, Genetics, Genetic Counseling/ Testing/ Therapy]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.143</dc:identifier>
<dc:title><![CDATA[Test Before You Stop--Reply [Correspondence]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>787</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>787</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/605?rss=1">
<title><![CDATA[About This Journal [About This Journal]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/605?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:title><![CDATA[About This Journal [About This Journal]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>605</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>605</prism:startingPage>
<prism:section>About This Journal</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/607?rss=1">
<title><![CDATA[Life, Surgery, and the Pursuit of Happiness [Presidential Address]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/607?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Gewertz, B. L.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Medical Practice, Medical Practice, Other, Surgery, Surgery, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.103</dc:identifier>
<dc:title><![CDATA[Life, Surgery, and the Pursuit of Happiness [Presidential Address]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>611</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>607</prism:startingPage>
<prism:section>Presidential Address</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/612?rss=1">
<title><![CDATA[Increased Lymph Node Evaluation With Colorectal Cancer Resection: Does It Improve Detection of Stage III Disease? [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/612?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Evaluation of 12 or more lymph nodes (LNs) with colorectal cancer (CRC) resection may not improve detection of stage III disease.</p>
<p><b>Design&nbsp;</b> Retrospective review after intervention.</p>
<p><b>Setting&nbsp;</b> Community teaching hospital.</p>
<p><b>Patients&nbsp;</b> We evaluated 701 consecutive operative CRC cases ascertained from our Cancer Registry.</p>
<p><b>Intervention&nbsp;</b> Patients undergoing resection before (n&nbsp;=&nbsp;553) a multidisciplinary initiative emphasizing the importance of LN counts were compared with those undergoing operation afterward (n&nbsp;=&nbsp;148).</p>
<p><b>Main Outcome Measures&nbsp;</b> Number of LNs evaluated, proportion of patients with stage III disease, and proportion of patients with N1 vs N2 disease.</p>
<p><b>Results&nbsp;</b> Demographic, tumor, and treatment variables were similar for both groups, except for younger age, fewer white patients, and more laparoscopic resections in the late period. Lymph node counts increased from a mean (SEM [median]) of 12.8 (0.3 [12]) to 17.3 (0.7 [16]) (<I>P</I>&nbsp;&lt;&nbsp;.001), with 53.0% of the early vs 71.6% of the late patients having at least 12 LNs examined. The proportion diagnosed as having stage III CRC was 204 of 553 (36.9%) for the early group vs 48 of 148 (32.4%) for the late group (<I>P</I>&nbsp;=&nbsp;.31). Among patients with positive LNs, the distribution of N1 and N2 disease was unchanged (early, 50.5% N1 and 49.5% N2; late, 54.2% N1 and 45.8% N2; <I>P</I>&nbsp;=&nbsp;.54).</p>
<p><b>Conclusions&nbsp;</b> Increased LN retrieval does not identify a greater number of patients with stage III CRC nor does it increase the proportion of patients with positive LNs with N2 disease. Our data suggest that harvest of at least 12 LNs as a quality or performance measure appears unfounded.</p>
]]></description>
<dc:creator><![CDATA[Kukreja, S. S., Esteban-Agusti, E., Velasco, J. M., Hieken, T. J.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Colon Cancer, Surgery, Surgical Interventions, Colorectal Surgery, Surgical Oncology, Diagnosis, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.112</dc:identifier>
<dc:title><![CDATA[Increased Lymph Node Evaluation With Colorectal Cancer Resection: Does It Improve Detection of Stage III Disease? [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>617</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>612</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/617?rss=1">
<title><![CDATA[Maintenance of Certification [Call for Papers]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/617?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:identifier>info:doi/10.1001/archsurg.2009.617</dc:identifier>
<dc:title><![CDATA[Maintenance of Certification [Call for Papers]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>617</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>617</prism:startingPage>
<prism:section>Call for Papers</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/618?rss=1">
<title><![CDATA[Assessment of Criteria and Clinical Significance of Circumferential Resection Margins in Esophageal Cancer [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/618?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To assess the clinical significance of circumferential resection margins according to current criteria of the College of American Pathologists (CAP) and the Royal College of Pathology (RCP) in esophageal and esophagogastric cancer.</p>
<p><b>Design&nbsp;</b> Prospective study.</p>
<p><b>Setting&nbsp;</b> Single-surgeon database.</p>
<p><b>Patients&nbsp;</b> One hundred thirty-five patients (mean age, 64 years) with T3 tumors who underwent esophageal resection for cancer between 1991 and 2006.</p>
<p><b>Main Outcome Measure&nbsp;</b> Resection margins criteria and survival.</p>
<p><b>Results&nbsp;</b> Three hundred seventy-four consecutive patients were prospectively identified from an institutional review board&ndash;approved database between 1991 and 2006. All patients with T3 tumors (n&nbsp;=&nbsp;135) had their original pathologic slides reassessed by a single gastrointestinal pathologist. Operative mortality was 0.7% and mean follow-up was 3.1 years. Follow-up was complete in 81% of patients. Positive margins were identified in 16 cases in the CAP group vs 83 cases in the RCP group. Five-year Kaplan-Meier survival curves in the CAP group demonstrated a significant (<I>P</I>&nbsp;&lt;&nbsp;.001) difference in survival, whereas the RCP group showed no difference (<I>P</I>&nbsp;=&nbsp;.20). In comparisons of negative vs positive margins, respectively, median survival in the CAP group (29.8 months [95% confidence interval (CI), 22.7-36.9] vs 8.33 months [95% CI, 4.4-12.3]) was significantly different from the RCP group (28.47 months [95% CI, 19.7-37.2] vs 22.23 months [95% CI, 13.6-30.8]). At 60-month follow-up, the positive predictive value with respect to survival was 100% in the CAP group vs 81% in the RCP group. Univariate and multivariate analyses identified R1 margins in the CAP group and lymph node ratio as being directly linked to survival.</p>
<p><b>Conclusions&nbsp;</b> Positive circumferential resection margins are prognostically important and the CAP criteria provide a more clinically meaningful assessment. Universal adoption of the CAP system can improve interpretation of international clinical trials and allow more accurate comparisons of outcomes.</p>
]]></description>
<dc:creator><![CDATA[Deeter, M., Dorer, R., Kuppusamy, M. K., Koehler, R. P., Low, D. E.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Gastrointestinal/ Upper Foregut, Surgical Oncology, Prognosis/ Outcomes, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.115</dc:identifier>
<dc:title><![CDATA[Assessment of Criteria and Clinical Significance of Circumferential Resection Margins in Esophageal Cancer [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>624</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>618</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/625?rss=1">
<title><![CDATA[Modulation of Mesenteric Lymph Flow and Composition by Direct Peritoneal Resuscitation From Hemorrhagic Shock [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/625?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Traditional clinical resuscitation from hemorrhagic shock that focuses on restoring central hemodynamic function does not adequately perfuse the gut. Intestinal hypoperfusion could stimulate ongoing organ failure and gut-derived systemic inflammatory response syndrome. Direct peritoneal resuscitation (DPR) that uses dialysis fluid improves perfusion and survival. We examined mesenteric lymph flow and proinflammatory constituents to determine whether DPR-stabilized interstitial compartment function could explain improved outcomes.</p>
<p><b>Design&nbsp;</b> A paired-control experimental animal study.</p>
<p><b>Participants&nbsp;</b> Mesenteric lymph fluid was continuously collected in 4 groups of rats (n&nbsp;=&nbsp;7 per group): sham group; hemorrhagic shock (50% mean arterial pressure for 30 minutes) and resuscitation (shed blood plus 2 volumes of isotonic sodium chloride for 30 minutes) group; hemorrhagic shock and resuscitation plus intraperitoneal saline (30 mL) group; and hemorrhagic shock and resuscitation plus DPR (30 mL of 2.5% clinical peritoneal dialysis fluid).</p>
<p><b>Interventions&nbsp;</b> Both DPR and saline were placed intraperitoneally at the time of resuscitation.</p>
<p><b>Main Outcome Measures&nbsp;</b> Lymph composition was analyzed by enzyme-linked immunosorbent assay (ELISA) for hyaluronic acid, its ligand CD44, and cytokines.</p>
<p><b>Results&nbsp;</b> Hemorrhagic shock and resuscitation elevated lymph flow (peak mean [SEM], 20.6&nbsp;[5.6] &micro;L/min at 60 minutes after resuscitation) and CD44 serum levels (peak mean [SEM], 140.0&nbsp;[12.9] ng/mL at 120 minutes after resuscitation) compared with the sham group (mean [SEM], 1.2&nbsp;[0.7] &micro;L/min and 15.6&nbsp;[1.5] ng/mL), and DPR returned levels to baseline (mean [SEM], 4.4&nbsp;[0.5] &micro;L/min and 15.4&nbsp;[0.3] ng/mL). Hyaluronic acid levels were elevated in the hemorrhagic shock and resuscitation group (mean [SEM], 90.0&nbsp;[1.3] ng/mL) and the hemorrhagic shock and resuscitation plus intraperitoneal saline group (mean [SEM], 93.0&nbsp;[1.3] ng/mL) compared with the sham group (mean [SEM], 73.7&nbsp;[1.4] ng/mL) or DPR group (81.2&nbsp;[0.9] ng/mL). Interferon , interleukin 1&beta;, interleukin 6, and interleukin 10 levels were also modulated by DPR.</p>
<p><b>Conclusions&nbsp;</b> Hemorrhagic shock and resuscitation increased lymph flow by altering capillary water transport and expanding interstitial volume. Increased lymph hyaluronic acid and inflammatory cytokines with traditional resuscitation were modulated to sham levels by DPR. In addition, DPR reduces these patterns presumably via an osmotic effect on capillary water transport. Adjunctive DPR might offer novel protection from systemic inflammatory response syndrome after hemorrhagic shock and resuscitation.</p>
]]></description>
<dc:creator><![CDATA[Matheson, P. J., Mays, C. J., Hurt, R. T., Zakaria, E. R., Richardson, J. D., Garrison, R. N.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Critical Care/ Intensive Care Medicine, Adult Critical Care, Surgery, Surgical Physiology, Surgical Cytokines]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.125</dc:identifier>
<dc:title><![CDATA[Modulation of Mesenteric Lymph Flow and Composition by Direct Peritoneal Resuscitation From Hemorrhagic Shock [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>634</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>625</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/634?rss=1">
<title><![CDATA[Errors in Table in: National Outcomes After Gastric Resection for Neoplasm [Correction]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/634?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgical Interventions, Gastrointestinal/ Upper Foregut, Surgical Oncology, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.105</dc:identifier>
<dc:title><![CDATA[Errors in Table in: National Outcomes After Gastric Resection for Neoplasm [Correction]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>634</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>634</prism:startingPage>
<prism:section>Correction</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/635?rss=1">
<title><![CDATA[Women Surgeons in the New Millennium [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/635?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Women are increasingly entering the surgical profession.</p>
<p><b>Objective&nbsp;</b> To assess professional and personal/family life situations, perceptions, and challenges for women vs men surgeons.</p>
<p><b>Design&nbsp;</b> National survey of American Board of Surgery&ndash;certified surgeons.</p>
<p><b>Participants&nbsp;</b> A questionnaire was mailed to all women and men surgeons who were board certified in 1988, 1992, 1996, 2000, or 2004. Of 3507 surgeons, 895 (25.5%) responded. Among these, 178 (20.3%) were women and 698 (79.7%) were men.</p>
<p><b>Results&nbsp;</b> Most women and men surgeons would choose their profession again (women, 82.5%; men, 77.5%; <I>P</I>&nbsp;=&nbsp;.15). On multivariate analysis, men surgeons (odds ratio [OR], 2.5) and surgeons of a younger generation (certified in 2000 or 2004; OR, 1.3) were less likely to favor part-time work opportunities for surgeons. Most of the surgeons were married (75.6% of women vs 91.7% of men, <I>P</I>&nbsp;&lt;&nbsp;.001). On multivariate analysis, women surgeons (OR, 5.0) and surgeons of a younger generation (OR, 1.9) were less likely to have children. More women than men surgeons had their first child later in life, while already in surgical practice (62.4% vs 32.0%, <I>P</I>&nbsp;&lt;&nbsp;.001). The spouse was the offspring's primary caretaker for 26.9% of women surgeons vs 79.4% of men surgeons (<I>P</I>&nbsp;&lt;&nbsp;.001). More women surgeons than men surgeons thought that maternity leave was important (67.8% vs 30.8%, <I>P</I>&nbsp;&lt;&nbsp;.001) and that child care should be available at work (86.5% vs 69.7%, <I>P</I>&nbsp;&lt;&nbsp;.001).</p>
<p><b>Conclusions&nbsp;</b> Women considering a surgical career should be aware that most women surgeons would choose their profession again. Strategies to maximize recruitment and retention of women surgeons should include serious consideration of alternative work schedules and optimization of maternity leave and child care opportunities.</p>
]]></description>
<dc:creator><![CDATA[Troppmann, K. M., Palis, B. E., Goodnight, J. E., Ho, H. S., Troppmann, C.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Medical Practice, Medical Education, Surgery, Surgery, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.120</dc:identifier>
<dc:title><![CDATA[Women Surgeons in the New Millennium [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>642</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>635</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/643?rss=1">
<title><![CDATA[The Effectiveness of Radioguided Parathyroidectomy in Patients With Negative Technetium Tc 99m-Sestamibi Scans [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/643?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Many surgeons have shown that radio-guided resection of parathyroid glands can facilitate intraoperative localization in selected patients with primary hyperparathyroidism, especially in the reoperative setting. However, in patients with negative technetium Tc 99m&ndash;sestamibi (hereafter referred to as "sestamibi") scans, the usefulness of the gamma probe is unclear. Thus, we were interested in determining the role of radio-guided techniques in patients with primary hyperparathyroidism and negative or nonlocalizing sestamibi scans.</p>
<p><b>Design&nbsp;</b> Retrospective analysis of a prospective parathyroid database.</p>
<p><b>Setting&nbsp;</b> Academic medical center.</p>
<p><b>Patients&nbsp;</b> Seven hundred sixty-nine patients with primary hyperparathyroidism who had a sestamibi scan and underwent surgical invention by a single surgeon. All patients had radioguided parathyroidectomy using a handheld gamma probe.</p>
<p><b>Main Outcome Measures&nbsp;</b> Radioactive counts, eucalcemia rate, and complications were compared between patients with positive and patients with negative sestamibi scans.</p>
<p><b>Results&nbsp;</b> All enlarged parathyroid glands were localized with the gamma probe in patients with a negative or with a positive sestamibi scan with similar sensitivities. This occurred despite the fact that smaller parathryoid glands were present, on average, in patients with negative sestamibi scans (428 mg vs 828 mg, <I>P</I>&nbsp;=&nbsp;.001). Equivalent high postoperative eucalcemia rates (>98%) and low complication rates (0.5%) were achieved with radioguided techniques in both patient populations.</p>
<p><b>Conclusions&nbsp;</b> Radioguided techniques are equally effective in patients with negative (nonlocalizing) sestamibi scans undergoing parathyroidectomy for primary hyperparathyroidism. Moreover, use of the gamma probe led to the detection of all parathyroid glands, including ectopically located ones. These data suggest that the gamma probe has an important role for localization of parathyroid glands in patients with negative preoperative sestamibi scans.</p>
]]></description>
<dc:creator><![CDATA[Chen, H., Sippel, R. S., Schaefer, S.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Radiology of Head & Neck, Radiologic Imaging, Surgery, Surgical Interventions, Endocrine Surgery, Radiography, Radionuclide Imaging]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.104</dc:identifier>
<dc:title><![CDATA[The Effectiveness of Radioguided Parathyroidectomy in Patients With Negative Technetium Tc 99m-Sestamibi Scans [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>648</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>643</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/649?rss=1">
<title><![CDATA[Accuracy of Fine-Needle Aspiration Biopsy for Predicting Neoplasm or Carcinoma in Thyroid Nodules 4 cm or Larger [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/649?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> All thyroid nodules 4 cm or larger should be surgically removed regardless of fine-needle aspiration biopsy (FNAB) results because of an unacceptably high rate of false-negative preoperative biopsy results in these large nodules.</p>
<p><b>Design&nbsp;</b> Retrospective cohort study.</p>
<p><b>Setting&nbsp;</b> Single-institution, tertiary academic referral center. </p>
<p><b>Patients&nbsp;</b> A retrospective analysis was performed on all patients who underwent surgery for a thyroid nodule 4 cm or larger from May 1, 1994, through January 31, 2007.</p>
<p><b>Main Outcome Measures&nbsp;</b> Preoperative FNAB results were correlated with final surgical pathologic results. The FNAB results were reported as nondiagnostic, benign, inconclusive (follicular neoplasm), or malignant, whereas the final surgical pathologic data were reported as benign or malignant.</p>
<p><b>Results&nbsp;</b> Of 155 patients who underwent a thyroidectomy for a nodule 4 cm or larger, 21 patients (13.5%) had a clinically significant thyroid carcinoma within the nodule on final pathologic analysis. Preoperative cytologic testing of the mass was performed on 97 patients, and the results read as benign for 52, inconclusive for 23, nondiagnostic for 11, and malignant for 11. In lesions 4 cm or larger, 26 of 52 FNAB results reported as benign (50.0%) turned out to be either neoplastic (22) or malignant (4) on final pathologic analysis. Among patients with nondiagnostic FNAB results, the risk of malignant neoplasms was 27.3%.</p>
<p><b>Conclusions&nbsp;</b> In patients with thyroid nodules 4 cm or larger, the FNAB results are highly inaccurate, misclassifying half of all patients with reportedly benign lesions. Furthermore, those patients with a nondiagnostic FNAB result display a high risk of differentiated thyroid carcinoma. Therefore, we recommend that diagnostic lobectomy be strongly considered in patients with thyroid nodules 4 cm or larger regardless of FNAB cytologic test results.</p>
]]></description>
<dc:creator><![CDATA[Pinchot, S. N., Al-Wagih, H., Schaefer, S., Sippel, R., Chen, H.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Neoplasms of Head & Neck, Surgery, Surgical Interventions, Endocrine Surgery, Surgical Oncology, Surgical Physiology, Surgical Physiology, Other, Diagnosis, Endocrine Diseases, Thyroid/ Parathyroid Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.116</dc:identifier>
<dc:title><![CDATA[Accuracy of Fine-Needle Aspiration Biopsy for Predicting Neoplasm or Carcinoma in Thyroid Nodules 4 cm or Larger [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>655</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>649</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/656?rss=1">
<title><![CDATA[Implementation of a Real-time Compliance Dashboard to Help Reduce SICU Ventilator-Associated Pneumonia With the Ventilator Bundle [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/656?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Ventilator-associated pneumonia (VAP) causes significant morbidity and mortality in critically ill surgical patients. Recent studies suggest that the success of preventive measures is dependent on compliance with ventilator bundle parameters.</p>
<p><b>Hypothesis&nbsp;</b> Implementation of an electronic dashboard will improve compliance with the bundle parameters and reduce rates of VAP in our surgical intensive care unit (SICU).</p>
<p><b>Design&nbsp;</b> Time series analysis of VAP rates between January 2005 and July 2008, with dashboard implementation in July 2007.</p>
<p><b>Setting&nbsp;</b> Multidisciplinary SICU at a tertiary-care referral center with a stable case mix during the study period.</p>
<p><b>Patients&nbsp;</b> Patients admitted to the SICU between January 2005 and July 2008.</p>
<p><b>Main Outcome Measures&nbsp;</b> Infection control data were used to establish rates of VAP and total ventilator days. For the time series analysis, VAP rates were calculated as quarterly VAP events per 1000 ventilator days. Ventilator bundle compliance was analyzed after dashboard implementation. Differences between expected and observed VAP rates based on time series analysis were used to estimate the effect of intervention.</p>
<p><b>Results&nbsp;</b> Average compliance with the ventilator bundle improved from 39% in August 2007 to 89% in July 2008 (<I>P</I>&nbsp;&lt;&nbsp;.001). Rates of VAP decreased from a mean (SD) of 15.2&nbsp;(7.0) to 9.3&nbsp;(4.9) events per 1000 ventilator days after introduction of the dashboard (<I>P</I>&nbsp;=&nbsp;.01). Quarterly VAP rates were significantly reduced in the November 2007 through January 2008 and February through April 2008 periods (<I>P</I>&nbsp;&lt;&nbsp;.05). For the August through October 2007 and May through July 2008 quarters, the observed rate reduction was not statistically significant.</p>
<p><b>Conclusions&nbsp;</b> Implementation of an electronic dashboard improved compliance with ventilator bundle measures and is associated with reduced rates of VAP in our SICU.</p>
]]></description>
<dc:creator><![CDATA[Zaydfudim, V., Dossett, L. A., Starmer, J. M., Arbogast, P. G., Feurer, I. D., Ray, W. A., May, A. K., Pinson, C. W.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Bacterial Infections, Infectious Diseases, Other, Critical Care/ Intensive Care Medicine, Adult Critical Care, Pulmonary Diseases, Pneumonia, Surgery, Surgical Physiology, Surgical Infections, Surgery, Other, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.117</dc:identifier>
<dc:title><![CDATA[Implementation of a Real-time Compliance Dashboard to Help Reduce SICU Ventilator-Associated Pneumonia With the Ventilator Bundle [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>662</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>656</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/663?rss=1">
<title><![CDATA[Need for a Revised Staging Consensus in Medullary Thyroid Carcinoma [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/663?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> Assessing prognosis for medullary thyroid cancer remains challenging and inexact. We hypothesize that the 1997 TNM staging criteria, especially for stage IV, are more accurate than the current 2002 staging system.</p>
<p><b>Design&nbsp;</b> Retrospective cohort study.</p>
<p><b>Setting&nbsp;</b> Tertiary referral center.</p>
<p><b>Patients&nbsp;</b> One hundred seventy-three patients surgically treated for medullary thyroid cancer from January 1, 1980, to December 31, 2007.</p>
<p><b>Main Outcome Measures&nbsp;</b> Patients were staged according to 1997 and 2002 TNM criteria and according to treatment result: biochemically cured (normal calcitonin level); clinically cured (elevated calcitonin level but no evidence of disease by imaging); or not cured. Survival was calculated from initial surgery to death or last follow-up. Analysis used McNemar test to compare paired proportions and Kaplan-Meier estimation with log-rank tests.</p>
<p><b>Results&nbsp;</b> A significantly higher proportion of patients were classified as having stage IV cancer using 2002 criteria compared with 1997 criteria (33% vs 7%, respectively; <I>P</I>&nbsp;&lt;&nbsp;.001). Stage IV, 5-year overall survival was 82% (95% confidence interval, 72%-93%) with 2002 criteria vs 46% (95% confidence interval, 22%-93%) with 1997 criteria. Despite 15 of 36 clinically cured patients (42%) being classified as having stage IV cancer (13 patients with stage IVa cancer, 2 patients with stage IVb cancer) by the 2002 criteria, the observed overall survival of the clinically cured group at 5, 10, and 15 years was 100%, 100%, and 79%, respectively (<I>P</I>&nbsp;=&nbsp;.7 compared with those biochemically cured).</p>
<p><b>Conclusions&nbsp;</b> The current 2002 TNM staging for medullary thyroid cancer appears inadequate, especially for patients with stage IV cancer. Elevated but stable calcitonin levels often do not portend unfavorable outcome. Patients with lymph node metastases, irrespective of their location, but without distant disease would seem best classified as having stage III cancer.</p>
]]></description>
<dc:creator><![CDATA[Boostrom, S. Y., Grant, C. S., Thompson, G. B., Farley, D. R., Richards, M. L., Hoskin, T. L., Hay, I. D.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Neoplasms of Head & Neck, Surgery, Surgical Interventions, Endocrine Surgery, Surgical Oncology, Prognosis/ Outcomes, Endocrine Diseases, Thyroid/ Parathyroid Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.122</dc:identifier>
<dc:title><![CDATA[Need for a Revised Staging Consensus in Medullary Thyroid Carcinoma [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>669</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>663</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/670?rss=1">
<title><![CDATA[An Evaluation of 2537 Gastrointestinal Stromal Tumors for a Proposed Clinical Staging System [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/670?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> A gastrointestinal stromal tumor (GIST) staging system can be created with the Surveillance, Epidemiology and End Results (SEER) database.</p>
<p><b>Design&nbsp;</b> A review of records in the SEER database from 2537 patients with GISTs from June 1, 1977, through August 1, 2004.</p>
<p><b>Patients and Methods&nbsp;</b> Patients were compared using all available clinicopathologic factors, and a TGM (tumor, grade, metastasis) staging system was created according to these parameters. Survival data were analyzed using Kaplan-Meier methods, log-rank analyses, and Cox regression models.</p>
<p><b>Results&nbsp;</b> Median follow-up time was 21 months, 47.6% of patients were men, and the median age was 64 years; 5.0% had lymph node involvement, and 22.6% had distant metastasis. Tumor size (T1, &le;70 mm; T2, >70 mm; <I>P</I>&nbsp;&lt;.001), grade (G1,&nbsp;grades I and II; G2, grades III and IV; <I>P</I>&nbsp;&lt;.001), and the presence of metastases (M0, no; M1, yes; <I>P</I>&nbsp;&lt;.001) did affect overall survival. When combined in a TGM staging system, grade and metastasis were the factors most predictive of survival.</p>
<p><b>Conclusions&nbsp;</b> A staging system for GISTs that provides valuable prognostic information was developed. Further work to refine this system and validate it with other data sets should be undertaken. Mitotic index and standardized reporting may provide additional prognostic information and should be recorded for all tumors so that the most accurate staging system can be created.</p>
]]></description>
<dc:creator><![CDATA[Woodall, C. E., Brock, G. N., Fan, J., Byam, J. A., Scoggins, C. R., McMasters, K. M., Martin, R. C. G.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Oncology, Other, Surgery, Surgical Interventions, Gastrointestinal/ Upper Foregut, Surgical Oncology, Prognosis/ Outcomes, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.108</dc:identifier>
<dc:title><![CDATA[An Evaluation of 2537 Gastrointestinal Stromal Tumors for a Proposed Clinical Staging System [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>678</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>670</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/679?rss=1">
<title><![CDATA[Comparison of Laparoscopic Inversion Esophagectomy and Open Transhiatal Esophagectomy for High-Grade Dysplasia and Stage I Esophageal Adenocarcinoma [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/679?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> The perioperative outcomes of laparoscopic inversion esophagectomy (LIE) are comparable to those of open transhiatal esophagectomy (THE), with potential benefits related to the use of minimally invasive techniques.</p>
<p><b>Design&nbsp;</b> Case-control study.</p>
<p><b>Setting&nbsp;</b> Tertiary care university hospital.</p>
<p><b>Patients and Interventions&nbsp;</b> From July 1, 2003, through March 31, 2008, 21 consecutive patients underwent LIE for high-grade dysplasia or clinical stage I esophageal cancer. We compared these patients with 21 stage-matched control patients treated with THE from August 1, 1995, through August 31, 2003.</p>
<p><b>Main Outcome Measures&nbsp;</b> Operative time, blood loss, length of hospital stay, perioperative complications, and disease-free survival.</p>
<p><b>Results&nbsp;</b> Mean (SD) operative times for LIE (399 [86] minutes) and THE (407 [127] minutes) were not significantly different (<I>P</I>&nbsp;=&nbsp;.80). Patients undergoing LIE had significantly lower intraoperative blood loss (168 mL; <I>P</I>&nbsp;&lt;&nbsp;.001) and overall length of hospital stay (10 days; <I>P</I>&nbsp;=&nbsp;.03) compared with those in the THE group (526 mL and 14 days, respectively). Complication rates were not significantly different between the groups. With a median follow-up of 29 months, there has been 1 systemic recurrence in the LIE group.</p>
<p><b>Conclusions&nbsp;</b> Laparoscopic inversion esophagectomy is a safe and effective approach to the treatment of high-grade dysplasia and early esophageal adenocarcinoma. Compared with THE, LIE decreases operative blood loss and length of hospital stay without increasing the operative time, morbidity, or mortality related to esophagectomy.</p>
]]></description>
<dc:creator><![CDATA[Perry, K. A., Enestvedt, C. K., Pham, T., Welker, M., Jobe, B. A., Hunter, J. G., Sheppard, B. C.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Oncology, Other, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Gastrointestinal/ Upper Foregut, Surgical Oncology, Surgical Interventions, Other, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.113</dc:identifier>
<dc:title><![CDATA[Comparison of Laparoscopic Inversion Esophagectomy and Open Transhiatal Esophagectomy for High-Grade Dysplasia and Stage I Esophageal Adenocarcinoma [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>684</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>679</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/684?rss=1">
<title><![CDATA[Devices, Products, and Other 1-Time-Use Items in the Operating Room [Call for Papers]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/684?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Surgery, Surgery, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.684</dc:identifier>
<dc:title><![CDATA[Devices, Products, and Other 1-Time-Use Items in the Operating Room [Call for Papers]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>684</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>684</prism:startingPage>
<prism:section>Call for Papers</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/685?rss=1">
<title><![CDATA[Treatment for Blunt Cerebrovascular Injuries: Equivalence of Anticoagulation and Antiplatelet Agents [Paper]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/685?rss=1</link>
<description><![CDATA[
<p><b>Hypothesis&nbsp;</b> We hypothesize that the 2 antithrombotic treatment regimens, systemic heparin sodium vs antiplatelet agents, are equivalent for the treatment of blunt cerebrovascular injuries (BCVIs) to prevent devastating injury-related strokes.</p>
<p><b>Design&nbsp;</b> Retrospective review of a prospective database.</p>
<p><b>Setting&nbsp;</b> Level I trauma center.</p>
<p><b>Patients&nbsp;</b> Patients with BCVIs from January 1, 1997, to January 1, 2007.</p>
<p><b>Main Outcome Measures&nbsp;</b> Incidence of cerebrovascular accident (CVA), stratified by treatment.</p>
<p><b>Results&nbsp;</b> During the study period, 422 BCVIs were identified in 301 patients (64.8% men; mean [SEM] age, 37.0&nbsp;[0.8] years; mean [SEM] injury severity score, 27.0&nbsp;[0.9]). A total of 22 patients presented with neurologic ischemia, and 5 patients sustained CVAs after embolization and/or stenting of an injury. Treatment was initiated for 282 asymptomatic BCVIs (heparin, 192; aspirin, 67; aspirin and/or clopidogrel, 23); 1 patient had a CVA (0.5%). Of 107 patients with untreated, asymptomatic BCVIs, 23 (21.5%) had a CVA. For untreated patients sustaining BCVI-related CVAs, the mean (SEM) time to diagnosis was 58&nbsp;(10) hours. For those who did not exhibit symptoms within 2 hours of injury, mean time to diagnosis of CVA was 75&nbsp;(11) hours. Injury healing rates (heparin, 39%; aspirin, 43%; aspirin/clopidogrel, 46%) and injury progression rates (12%; 10%; 15%) were equivalent between therapeutic regimens.</p>
<p><b>Conclusions&nbsp;</b> With an overall CVA risk of 21% and a documented latent period, comprehensive screening, early diagnosis, and institution of antithrombotic therapy for BCVI are clearly warranted. The type of treatment, heparin vs antiplatelet agents, does not appear to affect either stroke risk or injury healing rates.</p>
]]></description>
<dc:creator><![CDATA[Cothren, C. C., Biffl, W. L., Moore, E. E., Kashuk, J. L., Johnson, J. L.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Thrombolysis, Neurology, Cerebrovascular Disease, Stroke, Cardiovascular System, Surgery, Surgery, Other, Drug Therapy, Drug Therapy, Other, Cardiovascular Intervention]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.111</dc:identifier>
<dc:title><![CDATA[Treatment for Blunt Cerebrovascular Injuries: Equivalence of Anticoagulation and Antiplatelet Agents [Paper]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>690</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>685</prism:startingPage>
<prism:section>Paper</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/691?rss=1">
<title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/691?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Maglione, T., Yong, S., Velankar, M., Brems, J.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Radiologic Imaging, Surgery, Surgical Interventions, Surgical Oncology, Surgical Physiology, Surgical Physiology, Other, Diagnosis, Computed Tomography, Hematology/ Hematologic Malignancies, Leukemias/ Lymphomas, Immunology, Immunologic Disorders]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.119-a</dc:identifier>
<dc:title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>691</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>691</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/692?rss=1">
<title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/692?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Radiologic Imaging, Surgery, Surgical Interventions, Surgical Oncology, Surgical Physiology, Surgical Physiology, Other, Diagnosis, Computed Tomography, Hematology/ Hematologic Malignancies, Leukemias/ Lymphomas, Immunology, Immunologic Disorders]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.119-b</dc:identifier>
<dc:title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>692</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>692</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/693?rss=1">
<title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/693?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Shrivastav, A., Chakraborty, S.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Pain, Radiologic Imaging, Surgery, Surgical Interventions, Gastrointestinal/ Upper Foregut, Diagnosis, Radiography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.106-a</dc:identifier>
<dc:title><![CDATA[Image of the Month--Quiz Case [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>693</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>693</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

<item rdf:about="http://archsurg.ama-assn.org/cgi/content/short/144/7/694?rss=1">
<title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></title>
<link>http://archsurg.ama-assn.org/cgi/content/short/144/7/694?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:48 PDT</dc:date>
<dc:subject><![CDATA[Pain, Radiologic Imaging, Surgery, Surgical Interventions, Gastrointestinal/ Upper Foregut, Diagnosis, Radiography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archsurg.2009.106-b</dc:identifier>
<dc:title><![CDATA[Image of the Month--Diagnosis [Special Feature]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>144</prism:volume>
<prism:endingPage>694</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>694</prism:startingPage>
<prism:section>Special Feature</prism:section>
</item>

</rdf:RDF>